Revised Feb2020

CURRICULUM VITAE KATE M. GUTHRIE, Ph.D. (née Kathleen M. Morrow)

Business Addresses: Centers for Behavioral & Preventive Medicine The Miriam Hospital Coro West, Suite 309 One Hoppin Street Providence, RI 02903 Business Telephone: 401.793.8180 Business Fax: 401.793.8165 E-Mail Addresses: [email protected] or [email protected] ORCID ID: 0000-0002-5528-1212 Faculty Profile: https://vivo.brown.edu/display/kmguthri

EDUCATION

1986 B.A. St. Bonaventure University: Psychology 1986 St. Bonaventure University: Psi Chi Award, Department of Psychology 1990 M.A. West Virginia University: Clinical Psychology * American Psychological Association Accredited 1995-1996 Brown Medical School: Department of Psychiatry and Human Behavior, Brown University Clinical Psychology Training Consortium (Behavioral Medicine Track) Pre-Doctoral Internship. * American Psychological Association Accredited 1996 Ph.D. Western Michigan University: Clinical Psychology * American Psychological Association Accredited

POSTGRADUATE TRAINING

1996-1997 Center for Alcohol and Addiction Studies, Department of Community Health, Brown University, Providence, RI, Postdoctoral NIAAA Research Fellowship

POSTGRADUATE HONORS AND AWARDS

2003 Community Service Award. Centers for Behavioral & Preventive Medicine. Brown Medical School & The Miriam Hospital 2003 Citation Award. Morrow, K., Costello, T., & Rosen, R. (2003, March). Coloring in the Lines: Using Qualitative Data to Enhance Quantitative Findings: The Case of Microbicide Acceptability. Presented at the Annual Meeting of the Society of Behavioral Medicine. Annals of Behavioral Medicine, 25 (suppl), D47. 2008 M.A., (Honorary, Ad Eundem), Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University 2010-2011 Faculty Mentoring Award. Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University 2011 The Betty Marcus Women’s Health Endowment Fund Award, Recognizing and Promoting Excellence in Community Service, Research, and Clinical Services for Women 2018 OWIMS 2018 Leadership Award, Office of Women in Medicine and Science, Warren Alpert Medical School of Brown University 2019 Nominee, TEDxBrownU. Brown University.

- 1 - Revised Feb2020

PROFESSIONAL LICENSE

1998-present Licensed Psychologist, Rhode Island ID# PS00642

ACADEMIC APPOINTMENTS:

1998-1999 Investigator (Research), Department of Psychiatry & Human Behavior, Brown University School of Medicine 1998-present Training Faculty, Brown University Clinical Psychology Training Consortium 1999-2017 Training Faculty, Center for Alcohol and Addictions Studies, Brown University 2000-2017 Training Faculty, International Health Institute, Brown University 2003-2005 Adjunct Assistant Professor, Department of Psychology, Providence College 1999-2008 Assistant Professor (Research), Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University 2008-2017 Associate Professor (Research), Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University 2013-2017 Associate Professor (Research) (Secondary Appointment), Department of Behavioral & Social Sciences, Brown University School of Public Health 2017-present Professor (Research)/Professor (Research Scholar) (track change effective July 2018), Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University 2017-present Professor (Research)/Professor (Research Scholar) (track change effective July 2018), (Secondary Appointment), Department of Behavioral & Social Sciences, Brown University School of Public Health 2017-present Director, Qualitative Science Methods & Training Program, Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University

HOSPITAL APPOINTMENTS:

1998-present Staff Psychologist (1998-2013), Senior Research Scientist (2013-present: job title change); The Miriam Hospital, Providence, RI

OTHER APPOINTMENTS* * Includes volunteer and professional service roles

2000-present Reviewer (ad hoc, selected) for: • AIDS and Behavior • Journal of Sex Research • Sexually Transmitted Diseases • Social Science & Medicine • JAIDS : Journal of AIDS • Journal of Women’s Health • AIDS Research & Therapy • AIDS Care • BioMed Central • Annals of Behavior Medicine • Sierra Leone Journal of Biomedical Research • Journal of Applied Social Psychology • Women and Health • Substance Abuse • Behavior Modification • PLoS One • BMJ Open • American Journal of Public Health • Social Science & Medicine

2000 Invited Member, Special Emphasis Review Panel: Centers for Disease Control and Prevention (CDC) Program Announcement #00031, Sexually Transmitted Diseases/Human Immunodeficiency Virus Prevention Training Centers - 2 - Revised Feb2020

2003 Invited Member, Scientific Review Committee, Society of Behavioral Medicine 2006 Invited Member, Scientific Review Committee, Foundation for AIDS Research (amfAR) 2006 Invited Participant, “Opportunities for Improving HIV Diagnosis, Prevention & Access to Care in the US” Conference, Washington, DC 2007 Invited Member, Scientific Review Committee, Centers for Disease Control & Prevention (CDC), 2007 National Conference on HIV Prevention 2007-present Editorial Board, AIDS and Behavior 2007 Invited Reviewer, amfAR Issue Brief, HIV in Correctional Settings: Implications for Prevention and Treatment Policy 2007-2008 Invited Member, Scientific Review Committee, Track C (Behavioral & Social Sciences), International Microbicides 2008 Conference, New Delhi, India 2007-2010 Behavioral and Social Science Volunteers (BSSV), American Psychological Association 2009 Invited Reviewer, Centers for Disease Control and Prevention, National HIV Prevention Conference 2009-present Member, Steering Committee, International Rectal Microbicide Advocates (IRMA) 2009-present: Member, Lube Safety Committee 2009-2010: Member, 2010 Report Committee 2010-present Invited Member, Network of Experts, The Initiative for Multipurpose Prevention Technologies (IMPT) 2011 Invited Member, Scientific Advisory Committee, IRMA/ARM Rectal Microbicide Advocacy Video 2011 Study Section Member, RFA PAR 11-091 and PAR 11-092: Indo-US Program on Maternal and Child Health and Human Development Research (MCHDR) (R01 and R03, respectively) 2012-2013 Invited Member, HPTN 064 (ISIS) Qualitative Steering Committee 2014-2015 Consultant, Population Council, Inc. “Survey of Nanofiber Acceptability.” 2014-2016 Consultant, FHI360/USAID. Consortium for Ring Adherence. “Adherence Measurement and Optimization of Long-Acting ARV-based Vaginal Rings.” 2015-2020 Member, Data Safety Monitoring Board. Integrated Preclinical/Clinical Program, U19 AI113127 (Hendrix, PI). Development of Rectal Enema as Microbicide (DREAM).

HOSPITAL COMMITTEES

1999-2003 Editor, CenterScape newsletter committee, Centers for Behavioral & Preventive Medicine, The Miriam Hospital & Warren Alpert Medical School of Brown University 2005 Faculty Representative, Job Description Task Force, CBPM, The Miriam Hospital 2006-2010 Scientific Review Member, Betty Marcus Women’s Health Endowment Fund, The Miriam Hospital 2008 Patient Experience Committee, The Miriam Hospital/Lifespan 2015-2016 Lifespan ad hoc Committee on Patient/Research Participant Computer Access

- 3 - Revised Feb2020

UNIVERSITY COMMITTEES

1998-present Member, Faculty Committee, Centers for Behavioral & Preventive Medicine, Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University 2001-present Member, Research Operations Committee, Centers for Behavioral & Preventive Medicine, Department of Psychiatry & Human Behavior, Warren Alpert Medical School of Brown University. (The Research Operations Committee meets, at present, on an ad hoc basis only.) 2006-2011 Member (Chair: 2009-2010), Faculty Academic Advisory Committee, Centers for Behavioral and Preventive Medicine, Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University. (The FAAC was discontinued end of year 2011.) 2009 Planning Committee, NIH Office of Research on Women’s Health (ORWH), National Strategic Planning Workshop MEMBERSHIP IN SOCIETIES

Member, American Psychological Association Member, American Psychological Association, Division 38 (Society for Health Psychology) Member, Association of Reproductive Health Professionals Fellow, Society of Behavioral Medicine Member, International Society of Behavioral Medicine Member, American Public Health Association Member, PHCR, Pulmonary Hypertension Clinicians & Researchers Member, AAHPM, American Academy of Hospice and Palliative Medicine

PUBLICATIONS LIST

ORIGINAL RESEARCH IN PEER-REVIEWED JOURNALS ** signifies publications where Dr. Guthrie (née Morrow) served as a primary mentor and/or qualitative methodology mentor ¥ indicates a Review

1. Sundby, S., Morrow, K., DeVries, J., & Poling, A. (1996). Attitudes of American midwestern undergraduates towards male and female AIDS patients. College Student Journal, 30, 24-28. 2. Osowiecki, D., Cohen, R., Morrow, K., Flanigan, T., & Boland, R. (2000). Neurocognitive and psychological contributions to quality of life in HIV-1 infected women. AIDS, 14, 1327-1332. PMID: 10930146. 3. ¥ Niaura, R., Shadel, W., Morrow, K., Flanigan, T., & Abrams, D. (2000). HIV, AIDS, and smoking cessation: The time is now. Journal of Clinical Infectious Diseases, 31, 808-12. PMID: 11017836. 4. Bentley, M., Morrow, K., Fullem, A., Chesney, M., Horton, S., Rosenberg, Z., & Mayer, K. (2000). Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Family Planning Perspectives, 32, 184-188. [Name changed to Perspectives on Sexual and Reproductive Health]. PMID: 10942354. 5. Morrow, K., & Allsworth, J. (2000). Sexual risk in lesbian and bisexual women. Journal of the Gay and Lesbian Medical Association, 4, 159-165. doi: 10.1023/A:1026507721501. 6. Morrow, K., Costello, T., Boland, R. (Nov/Dec 2001). Understanding the Psychosocial Needs of HIV-Positive Women: A Qualitative Study. Psychosomatics, 42, 497-503. PMID: 11815685. 7. Morrow, K., Rosen, R., Richter, L., Emans, A., Forbes, A., Day, J., Morar, N., Maslankowski, L., Profy, A.T., Kelly, C., Abdool Karim, S., & Mayer, K. (2003). The acceptability of an investigational vaginal microbicide, PRO 2000 Gel in the context of a Phase I clinical trial. Journal of Women’s Health, 12, 655-666. PMID: 14583106. 8. MacGowan, R.J., Margolis, A., Gaiter, J., Morrow, K., Zack, B., Askew, J., McAuliffe, T., Sosman, J.M., Eldridge, G., and the Project START Study Group. (2003). Predictors of risky sex of young men after release from prison. International Journal of STD and AIDS, 14, 519-523. PMID: 12935380.

- 4 - Revised Feb2020

9. Mason, T.H., Foster, S.E., Finlinson, H.A., Morrow, K.M., Rosen, R., Vining-Bethea, S., Joanis, C.L., Hammet, T.M., Seage, G.R. (2003). Perspectives on vaginal microbicides among women with drug-related HIV risks in three cities in the U.S. and Puerto Rico. AIDS & Behavior, 7, 339-351. PMID: 14707531. 10. Morrow, K., Costello, T. (2004). HIV, STD and Hepatitis Prevention among Women in Methadone Maintenance: A Qualitative and Quantitative Needs Assessment. AIDS Care, 16, 426-433. PMID: 15203411. 11. Seal, D., Belcher, L., Morrow, K., Eldridge, G., Binson, D., Kacanek, D., Margolis, A., McAuliffe, T., Simms, R. & The Project START Study Group (2004). A qualitative study of substance use and sexual behavior among 18- to 29- year old men while incarcerated in the United States. Health Education and Behavior, 31, 775-789. PMID: 15539547. 12. Grinstead, O., Faigeles, B., Comfort, M., Seal, D., Nealey-Moore, J., Belcher, L., Morrow, K. and the Project START Study Group. (2005). HIV, STD, and hepatitis risk to primary female partners of men being released from prison. Women and Health, 41, 63-80. PMID: 16219588. 13. ** Buck, J.M., Morrow, K.M., Margolis, A., Eldridge, G., Sosman, J., Binson, D., MacGowan, R., Kacanek, D., Flanigan, T.P., & The Project START Study Group. (2006). Hepatitis B vaccination in prison: The perspectives of formerly incarcerated men. Journal of Correctional Health Care, 12, 12-23. doi: 10.1177/1078345806287937. *Dr. Morrow was mentor for Ms. Buck and contributed to this manuscript in equal part with Ms. Buck. 14. El-Sadr, W.M., Mayer, K.H., Maslankowski, L., Hoesley, C., Justman, J., Gai, F., Mauck, C., Absalon, J., *Morrow, K., Mâsse, B., Soto-Torres, L. & Kwiecien, A. for the HIV Prevention Trials Network (HPTN) 049 Protocol Team. (2006). Safety and Acceptability of Cellulose Sulfate as a Vaginal Microbicide in HIV-infected Women. AIDS, 20, 1109-1116. PMID: 16691061. *Dr. Morrow was the Chair of the Acceptability Substudy for this project and is the only behavioral scientist in this Phase 1 clinical trial author group. 15. Mayer, K.H., Maslankowski, L.A., Gai, F., El-Sadr, W.M., Justman, J., Kwiecien, A., Mâsse, B., Eshleman, S.H., Hendrix, C., *Morrow, K., Rooney, J.F., Soto-Torres, L., & the HPTN 050 Protocol Team (2006). Safety and tolerability of Tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS, 20, 543-551. PMID: 16470118. *Dr. Morrow was the Chair of the Acceptability Substudy for this project and is the only behavioral scientist in this Phase 1 clinical trial author group. 16. Morrow, K.M., Eldridge, G., Nealey-Moore, J., Grinstead, O., Belcher, L., Askew, J., & the Project START Study Group. (2007). HIV, STD, and hepatitis risk in the week following release from prison: An event-level analysis. Journal of Correctional Health Care, 13, 27-38. doi: 10.1177/1078345807299457. 17. Morrow, K.M., Fava, J.L., Rosen, R.K., Christensen, A.L., Vargas, S. & Barroso, C. (2007). Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type. Health Psychology, 26, 777-786. PMID: 18020851. 18. Carballo-Diéguez A., Balan I., Morrow K., Rosen R., Mantell J., Gai F., Hoffman S., Maslankowski L., El-Sadr W., Mayer K. (2007). Acceptability of Tenofovir gel as a vaginal microbicide by male participants in a phase I clinical trial (HPTN 050). AIDS Care, 19, 1026-1031. PMID: 17852000. 19. Morrow, K.M., Vargas, S., Rosen, R.K., Christensen, A.L., Salomon, L., Shulman, L., Barroso, C., Fava, J.L. (2007). The utility of non-proportional quota sampling for recruiting at-risk women for microbicide research. AIDS & Behavior, 11, 586-595. PMID: 17333312. 20. Morrow, K.M., Fava, J.L., Rosen, R.K., Vargas, S., Barroso, C., Christensen, A.L., Woodsong, C., Severy, L. (2007). Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties. Journal of Acquired Immune Deficiency Syndromes, 45, 93-101. PMID: 17325607. 21. Seal, D.W., Margolis, A.D., Morrow, K., Belcher, L., Sosman, J., & the Project START Study Group. (2008). Substance use and sexual behavior during incarceration among 18- to 29-year old men: Prevalence and correlates. AIDS & Behavior, 12, 27-40. PMID: 17345144. 22. ** Rosen, R., Morrow, K., Carballo-Diéguez, A., Mantell, J., Hoffman, S, Gai, F., Maslankowski, L., El-Sadr, W., & Mayer, K. (2008). Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed- methods study. Journal of Women’s Health, 17, 383-392. PMID: 18328009. *Dr. Morrow was primary mentor for Dr. Rosen and contributed to this manuscript in equal part with Dr. Rosen. 23. ** Lally, M.A., Montstream-Quas, S.A., Tanaka, S., Tedeschi, S.K., & Morrow, K.M. (2008). A qualitative study among injection drug using women in Rhode Island: Attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care & STD, 22, 53-64. PMID: 18095839. 24. Lloyd-Richardson E.E., Stanton C.A., Papandonatos G.D., Betancourt R.M., Stein M., Tashima K., Morrow K., Niaura R. (2008). HIV-positive smokers considering quitting: Differences by race/ethnicity. American Journal of Health Behavior, 32, 3-15. PMID: 18021029.

- 5 - Revised Feb2020

25. Morrow, K.M., &. Ruiz, M.S. (2008). Assessing Microbicide Acceptability: A Comprehensive and Integrated Approach. AIDS & Behavior, 12, 272-283. PMID: 17592763. 26. Exner, T., Correale, J., Carballo-Diéguez, A., Salomon, L., Morrow, K.M., Dolezal, C., Mayer, K. (2008). Women's anal sex practices: implications for formulation and promotion of a rectal microbicide. AIDS Education & Prevention, 20, 148-59. PMID: 18433320. 27. Grinstead, O., Eldridge, G., MacGowan, R., Morrow K.M., Seal, D., Sosman, J.M., Zack, B., and the Project START Study Group. (2008). An HIV, STD and Hepatitis Prevention Program for Young Men Leaving Prison: Project START. Journal of Correctional Health Care, 14, 183-196. doi: 10.1177/1078345808318217. 28. Morrow, K.M., for the Project START Study Group. (2009). HIV, STD, and Hepatitis Risk Behaviors of Young Men Before and After Incarceration. AIDS Care, 21, 235-243. PMID: 19229694. 29. Lloyd-Richardson, E.E., Stanton, C.A., Papandonatos, G.D., Shadel, W, Stein M., Tashima, K., Morrow, K., Neighbors, C., & Niaura, R. (2009). Motivation and Patch Treatment for HIV-Positive Smokers: A Randomized Controlled Trial. Addiction, 104, 1891-1900. PMID: 19719796. 30. ** Pekmezi, D.W., Neighbors, C.J., Lee, C.S., Gans, K.M., Bock, B.C., Morrow, K.M., Marques, B., Dunsiger, S., Marcus, B.H. (2009). A culturally adapted physical activity intervention for Latinas. American Journal of Preventive Medicine, 37, 495-500. PMID: 19944914. 31. Hoffman, S., Morrow, K.M., Mantell, J.E., Rosen, R.K., Carballo-Diéguez, A., Gai, F. (2010) Covert Use of a Vaginal Microbicide: Views of Women Participating in a Phase I Trial of Tenofovir Gel (HPTN 050). Archives of Sexual Behavior, 3, 748-760. PMID: 19636696. 32. Tolley, E.E., Harrison, P.F., Goetghebeur, E. Morrow, K., Pool, R, Taylor, D, Tillman, S.N., & van der Straten, A. (2010). Adherence and its measurement in Phase 2/3 microbicide trials. AIDS & Behavior, 14, 1124-1136. PMID: 19924525. 33. Buckheit R.W., Watson, K.M., Morrow, K.M., Ham, A.S. (2010). Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Research, 85, 142–158. PMID: 19874851. 34. ** Bock B.C., Morrow K.M., Becker B.M., Williams D.M., Tremont G., Gaskins R., Jennings E., Fava J. & Marcus B.H. (2010). Yoga as a complementary treatment for smoking cessation. Rationale, study design and participant characteristics of the quitting-in-balance study. BMC Complementary and Alternative Medicine, 10, 14-21. PMID: 20429895. 35. Ferrer R.A., Morrow K.M., Fisher W.A.,& Fisher J.D. (2010). Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials. AIDS Care, 14, 1-9. PMID: 20552466. 36. Gollub, E.L., Morrow, K.M., Mayer, K.H., Koblin, B.A., Peterside, P.B., Husnik, M.J., Metzger, D.S. (2010). Three city feasibility study of a body empowerment and HIV prevention intervention among women with drug use histories: Women FIT. Journal of Women’s Health, 19, 1705-1713. PMID: 20662629. 37. Morrow, K.M. & Hendrix, C. (2010). Clinical Evaluation of Microbicide Formulations. Antiviral Research, 88 (supp1), S40-46. PMC3053029. 38. ** Mahan, E.D., Morrow, K.M., & Hayes, J.E. (2011). Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: Implications for microbicide development. Contraception, 84, 184-193. PMID: 21757061. 39. McMahon, J.M., Morrow, K.M., Weeks, M., Morrison-Beedy, D., & Coyle, A. (2011). Potential impact of vaginal microbicides on HIV risk among women with primary heterosexual partners. Journal of the Association of Nurses in AIDS Care, 22, 9-16. PMID: 21211700. 40. ** Rabin, C., Simpson, N., Morrow, K., & Pinto, B. (2011). Behavioral and psychosocial program needs of young adult cancer survivors. Qualitative Health Research, 21(6), 796-806. PMID: 20705863. 41. Morrow, K.M., Rosen, R.K., Salomon, L., Woodsong, C., Severy, L., Vargas, S., Barroso, C. (2011). Using Integrated Mixed Methods to Develop Behavioral Measures of Factors Associated with Microbicide Acceptability. Qualitative Health Research, 21, 987-999. PMC4594875. 42. ** Rosengard, C., Tannis, C., Dove, D. C., van den Berg, J., Lopez, R., Stein, L.A.R., & Morrow, K. M. (2012). Family sources of sexual health information, primary messages, and sexual behavior of at-risk, urban adolescents. American Journal of Health Education, 43, 83-92. doi: 10.1080/19325037.2012.10599223. 43. ** Bock, B.C., Fava, J.L., Gaskins, R., Morrow, K.M., Williams, D.M., Jennings, E., Becker, B.M., Tremont, G., & Marcus, B.H. (2012). Yoga as a Complementary Treatment for Smoking Cessation in Women. Journal of Women’s Health, 21, 240-248. PMID: 21992583.

- 6 - Revised Feb2020

44. Johnson, AP, MacGowan, RJ, Eldridge, GD, Morrow, KM, Sosman, J, Zack, B, Margolis, A & The Project START Study Group. (2013). Cost and Threshold Analysis of an HIV/STI/Hepatitis Prevention Intervention for Young Men Leaving Prison: Project START. AIDS and Behavior, 17, 2676-2684. PMID: 22124581. 45. ** Rabin, C., Simpson, N., Morrow, K.M., Pinto, B. (2013). Intervention Format and Delivery Preferences among Young Adult Cancer Survivors. International Journal of Behavioral Medicine, 20, 304-310. PMID: 22328444. 46. ** Bock, B., Heron, K., Jennings, E., Magee, J.C., & Morrow, K.M. (2013). User Preferences for a Text Message- Based Smoking Cessation Intervention. Health Education & Behavior, 40, 152-159. PMID: 23086555. 47. Fava, J. L., van den Berg, J. J., Rosen R. K., Salomon, L. A., Vargas, S., Christensen, A. L., Pinkston, M., & Morrow, K. M. (2013). Measuring self-efficacy to use vaginal microbicides: The Microbicide Use Self-Efficacy (MUSE) instrument. Sexual Health, 10, 339-347. PMID: 23806676. 48. Marcus BH, Dunsiger SI, Pekmezi DW, Larsen BA, Bock BC, Gans KM, Marquez B, Morrow KM, Tilkemeier P. (2013). The Seamos Saludables Study: A Randomized Controlled Physical Activity Trial of Latinas. American Journal of Preventive Medicine, 45, 598-605. PMID: 24139773. 49. ** Bock, B., Heron, K., Jennings, E., Morrow, K.M., Cobb, V., Magee, J., Fava, J.L., Deutsch, C., Foster, R. (2013). A Text Message Smoking Cessation Intervention: The Pilot of TXT-2-Quit, a Randomized, Controlled Trial. JMIR Mhealth Uhealth (Journal of Medical Internet Research), 1(2): e17. PMID: 25098502. 50. Tolley, E.E., Morrow, K., Owen, D. (2013). Designing a Multipurpose Technology for Acceptability and Adherence. Antiviral Research, 100 Suppl: S 54-59. PMC4643455. 51. ** Underhill, K., Morrow, K.M., Operario, D., Mayer, K.H. (2014). Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men. AIDS and Behavior, 18, 241-249. PMC3968829. 52. ** van den Berg, J.J., Rosen, R.K., Bregman, D., Thompson, L., Jensen, K., Buckheit, K., Kiser, P., Katz, D., Buckheit, R., & Morrow, K.M. (2014). “Set it and forget it:” Women’s perceptions and acceptability of long-acting vaginal microbicide gels. AIDS & Behavior, 18, 862-870. PMC4327860. 53. Morrow, K.M., Underhill, K., van den Berg, J.J., Vargas, S., Rosen, R.K., Katz, D. (2014). User-Identified Gel Characteristics: A Qualitative Exploration of Perceived Product Efficacy of Topical Vaginal Microbicides. Archives of Sexual Behavior, 43, 1459-1467. PMID: 24452632. 54. Morrow, KM, Fava, JL, Rosen, RK, Vargas, SE, Shaw, JG, Kojic, E, Kiser, P, Friend, DF, Katz, D & The Project LINK Study Team. (2014). Designing preclinical measures to evaluate topical vaginal gel formulations: relating user perceptions and experiences to semisolid formulation properties. AIDS Research & Human Retroviruses, 30, 78-91. PMC3931431. ***High-Impact Article; most cited (Mary Anne Liebert Publishing)*** 55. ** Ranney, ML, Choo, EK, Cunningham, RM, Spirito, A, Thorsen, M, Mello, MJ, Morrow, K. (2014). Acceptability, language, and structure of text-message-based behavioral interventions for high-risk adolescent females: A qualitative study. Journal of Adolescent Health, 55, 33-40. PMC4065850. 56. MacQueen, KM, Tolley, EE, Owen, D, Amico, KR, Morrow, KM, Moench, T, Friend, D, Friedland, B. (2014). An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings. Journal of the International AIDS Society, 17(3 Suppl 2):19158. PMC4164000. 57. ** Underhill, K., Morrow, K.M., Colleran, C.M., Holcomb, R., Operario, D., Calabrese, S.K., Galarraga, O., & Mayer, K.H. (2014). Access to Healthcare, HIV/STI Testing, and Preferred Pre-Exposure Prophylaxis Providers among Men who Have Sex with Men and Men who Engage in Street-based Sex Work in the US. PLoS ONE. Nov 11;9(11):e112425. PMC4227700. 58. Marcus BH, Dunsiger SI, Pekmezi D, Larsen BA, Marquez B, Bock BC, Gans KM, Morrow KM, Tilkemeier P. (2015). Twelve-Month Physical Activity Outcomes in Latinas in the Seamos Saludables Trial. American Journal of Preventive Medicine, 48, 179-82. PMC5718346. 59. ** Underhill, K, Morrow, KM, Colleran, C, Holcomb R, Calabrese SK, Operario D, Galárraga O, Mayer KH. (2015). A Qualitative Study of Medical Mistrust, Perceived Discrimination, and Risk Behavior Disclosure to Clinicians by U.S. Male Sex Workers and Other Men Who Have Sex with Men: Implications for Biomedical HIV Prevention. Journal of Urban Health, 92, 667-686. PMC4524849. 60. ** Choo, EK, Ranney ML, Wetle T, Morrow K, Mello MJ, Squires D, Garro A, Tape C, Zlotnick C. (2015). Attitudes Toward Computer Interventions for Partner Abuse and Drug Use Among Women in the Emergency Department. Addictive Disorders and Their Treatment, 14, 95-104. PMC4498583. 61. ** Stanton, C.A., Papandonatos, G.D., Shuter, J., Bicki, A., Lloyd-Richardson, E.E., de Dios, M.A., Morrow, K., Makgoeng, S., Tashima, K.T., Niaura, R. (2015). Outcomes of a Culturally Tailored Intervention for Cigarette

- 7 - Revised Feb2020

Smoking Cessation among Latinos Living with HIV/AIDS. Nicotine & Tobacco Research, 17, 975-982. PMC4580545. 62. ** Choo, E. K., Garro, A., Ranney, M.L., Meisel, Z., & Guthrie, K. Morrow (2015). Qualitative Research in Emergency Care, Part I: Research Principles and Common Applications. Academic Emergency Medicine, 22, 1096- 1102. PMC4545270. 63. ** Ranney, M.L., Meisel, Z., Choo, E.K., Garro, A., Sasson, C., & Guthrie, K. Morrow (2015). Interview-based Qualitative Research in Emergency Care, Part II: Data Collection, Analysis and Results Reporting. Academic Emergency Medicine, 22, 1103-1112. PMC4560670. 64. Rosen, R.K., van den Berg, J.J., Vargas, S.E., Senocak, N., Shaw, J.G., Buckheit, R.W., Smith, K.A., and Morrow Guthrie, K. (2015). Meaning-making matters in product design: Users’ sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings. Contraception, 92, 596-601. PMC4664151. 65. Morrow Guthrie, K, Vargas, S, Shaw, JG, Rosen, RK, van den Berg, JJ, Kiser, PF, Buckheit, K, Bregman, D, Thompson, L, Jensen, K, Johnson, T, & Buckheit, RW. (2015). The promise of intravaginal rings for prevention: User perceptions of biomechanical properties and implications for prevention product development. PLoS One, 10: e0145642. PMC4690611. 66. ** Ranney, ML, Thorsen, M, Patena, JV, Cunningham, RM, Boyer, EW, Walton, MA, Spirito, A, Zatzick, DF, & Morrow, K. (2015). “You need to get them where they feel it”: Conflicting Perspectives on How to Maximize the Structure of Text-Message Psychological Interventions for Adolescents. Proceedings of the Hawaii International Conference on System Sciences, 3247-3255. PMC4669198. 67. ** Underhill, K., Morrow, K.M., Colleran, C.M., Calabrese, S.K., Operario, D., Salovey, P., & Mayer, K.H. (2016). Explaining the Efficacy of Pre-exposure Prophylaxis (PrEP) for HIV Prevention: A Qualitative Study of Message Framing and Messaging Preferences among US Men Who have Sex with Men. AIDS & Behavior. PMC4643421. 68. ** Vargas, SE, Fava, JL, Severy, L, Rosen, RK, Salomon, L, Shulman, L & Guthrie, K Morrow. (2016). Psychometric properties and validity of a multi-dimensional risk perception scale developed in the context of a microbicide acceptability study. Archives of Sexual Behavior, 45, 415-428. PMC4707104. 69. Guthrie, K Morrow, Dunsiger, S, Vargas, SE, Fava, JL, Shaw, JG, Rosen, RK, Kiser, P, Kojic, EM, Friend, DF, Katz, D, & The Project LINK Study Team. (2016). Perceptibility and the “Choice Experience”: User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. AIDS Research & Human Retroviruses, 32, 1022-1030. PMC5067921. 70. ** Choo, E., Guthrie, K Morrow, Mello, M., Wetle, T.F., Ranney, M., Tapé, C., Zlotnick, C. (2016). “I need to hear from women who have ‘been there’”: Developing a woman-focused intervention for drug use and partner violence in the emergency department. Partner Abuse, 7, 193-220. PMC5040444. 71. ** Ranney ML, Freeman JR, Connell G, Spirito A, Boyer E, Walton M, Guthrie KM, Cunningham RM, A (2016). Depression Prevention Intervention for Adolescents in the Emergency Department, Journal of Adolescent Health, 59, 401-410. PMC5035565. 72. ** Choo, E., Tapé, C., Glerum, KM, Mello, MJ, Zlotnick, C, & Guthrie, KM. (2016). “That’s Where the Arguments Come In”: A Qualitative Analysis of Booster Sessions Following a Brief Intervention for Drug Use and Intimate Partner Violence in the Emergency Department. Substance Abuse: Research & Treatment, 10, 77-87. PMC5021012. 73. Rosen RK, Thind H, Jennings E, Guthrie KM, Williams DM, & Bock BC (2016). “Smoking Does Not Go with Yoga”: A Qualitative Study of Women’s Phenomenological Perceptions during Yoga and Smoking Cessation. International Journal of Yoga Therapy, 26, 33-41. PMC6066608. 74. ** LaRose, JG, Guthrie, KM, Lanoye, A, Tate, DF, Robichaud, E, Caccavale, L, Wing, R. (2016). A mixed methods approach to improving recruitment and engagement of emerging adults in behavioural weight loss programs. Obesity Science & Practice, 2, 341-354. PMC5192532. 75. Weld, ED, Hiruy, H, Guthrie, KM, Fava, JL, Vargas, SE, Buckheit, K, Buckheit, RW, Spiegel, H, Breakey, J, Fuchs, EJ & Hendrix, CW. (2017). A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability. AIDS Research & Human Retroviruses, 33, 440-447. PMC5439405. 76. Guthrie, KM, Rosen, RK, Vargas, SE, Guillen, M, Steger, A, Getz, ML, Smith, KA, Ramirez, JJ, & Kojic, EM. (2017). User Input in Iterative Design for Prevention Product Development: Leveraging Interdisciplinary Methods to Optimize Effectiveness. Drug Delivery and Translational Research, 7, 761-770. doi: 10.1007/s13346-017-0397-0. PMC6103777 77. Guthrie, KM, Rohan, L, Rosen, RK, Vargas, S, Shaw, JG, Katz, D, Kojic, EM, Ham, A, Friend, D, Buckheit, K, Buckheit, RW. (2017). Vaginal Film for Prevention of HIV: Using Visual and Tactile Evaluations among Potential Users to Inform Product Design. Pharmaceutical Development & Technology, 23, 311-314. PMC5740013. - 8 - Revised Feb2020

78. ** Thorsen MM, Patena JV, Guthrie KM, Spirito A, Ranney ML. (2018). Using High-Risk Adolescents' Voices to Develop a Comprehensible Cognitive Behavioral Therapy-Based Text-Message Program. Behavioral Medicine, 44, 89-99. PMC5336547. 79. **Underhill, K, Guthrie, KM, Colleran, C, Calabrese SK, Operario, D & Mayer, KH. (2018). Temporal fluctuations in behavior, perceived HIV risk, and willingness to use pre-exposure prophylaxis (PrEP). Archives of Sexual Behavior, 47, 2109-2121. PMC6041197. 80. Guthrie, KM, Rosen, RK, Vargas, SE, Dawson, L, Getz, ML, Guillen, M, Ramirez, JJ, Baum, MB, & Vincent, KL. (2018). User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences. PLoS ONE. doi: 10.1371/journal.pone.0197269. PMC5951541 81. **Cioe, PA, Guthrie, KM, Freiberg, MS, Williams, DM, Kahler, CW. (2018). Cardiovascular Risk Reduction in Persons Living with HIV: Treatment Development, Feasibility, and Preliminary Results. Journal of the Association of Nurses in AIDS Care, 29, 163-177. PMC5816709. 82. **Claborn, K.R., Aston, E., Champion, J. & Guthrie, K. (2018). Prescribing opioids as an incentive to retain patients in medical care: A qualitative investigation into clinician awareness and perceptions. Journal of the Association of Nurses in AIDS Care, 29, 642-654. PMC6348082. 83. **Cioe, PA, Gordon, R, Guthrie, K., Kahler, CW. (2018). Perceived barriers to smoking cessation and perceptions of electronic cigarettes among persons living with HIV. AIDS Care, 30, 1469-1475. PMC6296254. 84. Vargas, SE, Banerjee, D, Guthrie, KM, Wickham, B, Allahua, M, Whittenhall, M, Palmisciano, A, & Ventetuolo, Corey. (2018). Sexual health and health-related quality of life among women with pulmonary arterial hypertension. Pulmonary Circulation. PMC 6102766. 85. Thind, H., Fava, J., Guthrie, K. Stroud, L., Gopalakrishnan, G., Sillice, M., Gidron, N., Bock, B.C. (2018). Yoga as a Complementary Therapy for Adults with Type 2 Diabetes: Design and Rationale of the Healthy Active and in Control (HA1C) Study. International Journal of Yoga Therapy, 28, 123-132. PMC6237625. 86. Vincent, KL, Moss, JA, Marzinke, MA, Hendrix, CW, Anton, PA, Pyles, RB, Guthrie, KM, Dawson, L, Olive, T, Butkyavichene, I, Churchman, SA, Cortez, Jr., JM, Fanter, R, Gunawardana, M, Miller, CS, Yang, F, Rosen, RK, Vargas, SE, & Baum, MM. (2018). Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial. PLoS Medicine, doi: 10.1371/journal.pmed.1002655. PMC6161852. 87. ** Zaveri, T, Powell, KA, Guthrie, KM, Bakke, AJ, Ziegler, GR, & Hayes, JE. (2018). Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories. BMC Women's Health, 18, 170. PMC6195955. 88. ** Carey, K.B., Guthrie, K.M., Rich, C.M., Krieger, N.H., Norris, A.L., Kaplan, C., & Carey, M.P. (2019). Alcohol use and sexual risk behavior in young women: A qualitative study. AIDS and Behavior. PMC6461532. 89. Bock BC, Thind H, Fava JL, Dunsiger S, Guthrie KM, Stroud L, Gopalakrishnan G, Sillice M, & Wu W. (2019). Feasibility of yoga as a complementary therapy for patients with type 2 diabetes: The Healthy Active and in Control (HA1C) study. Complementary Therapies in Medicine, 42, 125-131. PMID 30670230. 90. ** Thind, H., Guthrie, K., Horowitz, S., Conrad, M., Bock, B.C. (2019). “I can do almost anything:” The experience of adults with type 2 diabetes with a yoga intervention. Complementary Therapies in Clinical Practice, 34, 116-122. PMC6367938. 91. Norris, A.L., Rich, C., Krieger, N., Guthrie, K.M., Kaplan, C., Carey K.B., & Carey, M.P. (2019). Sexual risk behavior and substance use among young, diverse women seeking care at a reproductive health clinic. BMC Women’s Health, 19, 15. PMC6341714. 92. Vargas, SE, Midoun, MM, Guillen,M, Getz, ML, Underhill, K, Kuo, C, & Guthrie, KM. (2019). A qualitative systematic review of women’s experiences using contraceptive intravaginal rings: Implications for new technologies. Perspectives on Sexual and Reproductive Health, 51, 71-80. a. Co-published at Editor’s request in International Perspectives on Sexual and Reproductive Health, 45, 25-34. 93. ** Lu, CF, Vargas, SE, Guillen, M, Ramirez, JJ, Carbone, SL, Getz, ML, Frimpong, Y, Smith, KA, Shaw, JG, Tong, I, Hill, M, Berry, RE, Guthrie, KM. (2019). A qualitative study of the contraceptive effect on women’s sexual experience: Beyond hormonal effects. Obstetrics and Gynecology, 134(1), 91-101. 94. ** Lansing, A.H., Guthrie, K.M., Hadley, W.H., Stewart, A., Peters, A. & Houck, C. (in press). Qualitative Assessment of Emotion Regulation Strategies for Prevention of Health Risk Behaviors in Early Adolescents. Journal of Child and Family Studies. 95. ** Goldberg, E, Gettel, C, Hayes, K, Shield, R, Guthrie, KM. (in press). GAPcare: The Geriatric Acute and Post- Acute Fall Prevention Intervention for Emergency Department Patients – A qualitative evaluation. OBM Geriatrics. - 9 - Revised Feb2020

96. Vargas, SE, Norris, C, Landoll, R, Crone, B, Clark, Quinlan, J, & Guthrie, KM. (in press). Interventions to improve sexual and reproductive health in US active duty military servicemembers: A systematic review. American Journal of Health Promotion. 97. ** Gettel, C., Hayes, K., Shield, R., Guthrie, K.M., Goldberg, E. (in press). Care transition decisions after a fall- related ED visit: a qualitative study of patients' and caregivers' experiences. Academic Emergency Medicine.

CORPORATE AUTHORSHIP OR MULTICENTER TRIALS The Project START Study Group: Dr. Guthrie (née Morrow) was the Principal Investigator of the Rhode Island site in this 4-site CDC-funded Cooperative Agreement. Project START is honored to be amongst the CDC’s DEBI Programs (Diffusing Effective Behavioral Interventions). (See also citations # 8, 11, 12, 13, 16, 21, 27, 28 and 44, above.) 1. Seal D.W., Margolis A.D., Sosman J., Kacanek D., Binson D., and the Project START Study Group (2003). HIV and STD Risk Behavior among 18-25 Year Old Men Released From U.S. Prisons: Provider Perspectives. AIDS & Behavior, 7, 131-141. PMID: 14586198. 2. Grinstead O., Seal D.W., Wolitski R., Flanigan T., Fitzgerald C., Nealey-Moore J., Askew J., and the Project START Study Group. (2003). HIV and STD testing in prisons: perspectives of in-prison service providers. AIDS Education and Prevention, 15, 547-560. PMID: 14711167. 3. Sosman J.M., MacGowan R.J., Margolis A.D., Eldridge G., Flanigan T., Vardaman J., Fitzgerald C., Kacanek D., Binson D., Seal D.W., and the Project START Study Group. (2005). The Feasibility of STD and Hepatitis Screening Among 18-29 Year Old Men Recently Released From Prison. International Journal of STD & AIDS, 16, 117-122. PMID: 15825246. 4. Wolitski, R. and the Project START Writing Group for The Project START Study Group. (2006). The Effects of a Multi-Session Intervention on the Sexual Risk of Young Men Released from Prisons in 4 US States. American Journal of Public Health, 96, 1854-1861. PMC1586131. Dr. Morrow was the lead author from the Rhode Island site for this manuscript. 5. Seal, D.W., Eldridge, G., Kacanek, D., Binson, D., MacGowan, R., & the Project START Study Group. (2007). A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison. Social Science and Medicine, 65, 2394-2406. PMID: 17683839.

The Consortium for Ring Adherence: Dr. Guthrie served as a consultant on the project through FHI360. 6. Stalter, RM, Moench, TR, MacQueen, KM, Tolley, EE, Owen, DH, & the Consortium for Ring Adherence. (2016). Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings. Journal of the International AIDS Society, 19, 20746. PMC4854848.

BOOKS AND BOOK CHAPTERS (‡ indicates Invited Chapter)

1. ‡ Morrow, KM. (1995). Lesbian women and HIV/AIDS: An appeal for inclusion. In O'Leary, A. & Sweet Jemmott, L. (Eds.). Women at Risk: Issues in the Primary Prevention of AIDS, pp. 237-256. New York: Plenum. 2. ‡ Morrow, KM., Tolley, E. & Carballo-Dieguez, A. (2013). Topical Microbicide Acceptability. In Stanberry L & Rosenthal, S. (Eds.), 2nd edition. Sexually Transmitted Diseases, pp.229-250. Massachusetts: Elsevier.

PUBLICATIONS SUBMITTED ** signifies publications where Dr. Guthrie (née Morrow) served as either a qualitative methodology expert or mentor.

1. ** Brown, EK, Guthrie, KM, Stange, M, Creech, SK. (under review). "A Woman in a Man's World": Challenges Faced by Women Veterans During and After Deployment. 2. ** Tarantino, N, Guthrie, KM, & Armistead, L (under review). Protective parenting practices among mothers living with HIV and their adolescent children: A qualitative study. AIDS Care. 3. Vargas SE, Guillen M, Getz ML, Tong I, Hill M, Smith KA, Gellert GM, Fava JL, Dunsiger S, Ramirez JJ, Berry RE, Guthrie KM. (under review). Using mixed methods to understand sexual and reproductive health product use: Evaluating user experience in clinical trials. Contemporary Clinical Trials Communications. 4. Carbone, S., Guillen, M., Ramirez, JJ, Vargas, SE, Lu, CF, Getz, ML, Frimpong, Y, Smith, KA, Tong, I, Hill, M, Berry, RE, Harrison, A, & Guthrie, KM. (under review). “I feel like a person has a right to use a product to protect themselves…”: A Qualitative Study of the Risk-Benefit Calculus on Women’s Contraceptive Use and Choice. Sexual Health.

- 10 - Revised Feb2020

PUBLICATIONS IN PREPARATION ** signifies publications where Dr. Guthrie (née Morrow) serves as either a primary mentor, or qualitative methodology mentor.

1. Guthrie, KM, Fava, JL, Rosen, RK, Shaw, JG, Panameno, A, Colleran, C, Vargas, S, Kojic, E, Friend, DF, Katz, D, Buckheit, RW & The Project MIST Study Team. (planned submission). Understanding the role of volume in user sensory perceptions and experiences of vaginal formulations. 2. Guthrie, KM, Dunsiger, S, Vargas, SE, Guillen, M, Tong, I, Hill, M, Getz, ML, Ramirez, JJ, Ilg, G, & Berry, R (planned submission). Getting Over the Hump: Patterns of adherence (not compliance) in real world use of contraceptive intravaginal rings. (alternate title: Tracking Real World Use of Contraceptive Methods: Exploring the Utility of Ecological Momentary Assessment in SRH Research). 3. Guthrie, KM, Lantini, R,… (planned submission). Life’s Impositions: How Women’s Lives Influence Compensatory Behaviors to Realize Effective Contraceptive Use 4. **Vargas, SE, …. Guthrie, KM, (planned submission). Did I or Didn’t I? Daily versus 7-day Recall for Sexual Behaviors 5. Guthrie, KM, Dunsiger, S, Fava, JL, Rosen, RK, Katz, D, Rohan, L, Friend, DF, Buckheit, RW & The Project MIST Study Team. (planned submission). She said, he said: Users’ sensory perceptions and experiences inform microbicide choice.

INVITED PRESENTATIONS

Invitations from National Organizations/Conferences 1. Morrow, K. (July 2003). Vaginal microbicides: How did we get here and where are we going? Presented at the 2003 National HIV Prevention Conference, Atlanta, GA. 2. Morrow, K, & Rosen R. (March 2005). The Phoenix Project: Contextualizing Microbicide Acceptability. Presented at the Psychosocial Workshop, Philadelphia, PA. 3. Rosen, R. & Morrow, K. (March 2005). Microbicide Use: Qualitative Clues to Relationship Domains. Presented at the Psychosocial Workshop, Philadelphia, PA. 4. Morrow, K. (September 2005). Key Methodological Issues in Behavioral Research on Microbicides. Presented at the NIH Microbicide Workshop “Behavioral and Social Sciences Issues in Microbicide Research.” Bethesda, MD. 5. Morrow, K. (December 1, 2005). Microbicides: New hope for women – The Science of Microbicides. Presented at “Living Our Lives” 2005 World AIDS Day Event: AIDS Action Committee, Boston, MA. 6. Morrow, K. (February 2006). Topical Microbicides: Current Research on Preventing HIV Transmission in Women. Continuing Medical Education (CME) Workshop presented at Beth Israel Deaconness Medical Center, Women’s Health Center, Boston, MA. 7. Morrow K. (October 2006). You want me to use what? Rectal Microbicide Acceptability. Invited presentation at “The future of anal sex: What every booty should do” Community Forum presented by the AIDS Action Committee, Boston, MA. 8. Morrow, K. (December 2006). Topical microbicides: Current research on preventing HIV transmission in women. Invited presentation to the San Francisco AIDS Foundation, San Francisco, CA. 9. Morrow, KM & Rosen, R.K. (March 2007). The acceptability of pleasure: the sex appeal of vaginal microbicides. Invited Grand Rounds Presentation at the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University. 10. Morrow, KM. (April 2007). Cultural Translations of Interventions: Lessons Learned. Invited presentation for the DPHB Diversity Committee, The Warren Alpert Medical School of Brown University. 11. Rosen, RK & Morrow, KM. (April 2008). Using NVivo qualitative data management software: An overview and focus on team efforts. Presented to the Qualitative Methods Working Group, Population Studies and Training Center, Brown University. 12. Morrow, KM. (July 2009). Interdisciplinary Strategies for Developing Reproductive Health Promotion Methods. Invited presentation to the Women’s Reproductive Health Research Seminar, Women & Infants Hospital, Providence, RI. 13. Morrow, KM. (October 2009). Using Qualitative Studies in Formative and Evaluative Research. Invited oral presentation to the Department of Child Psychiatry, Rhode Island Hospital, Providence, RI. 14. Morrow, KM. (October 2009). Engineering an Anti-HIV Gel for User Acceptability. Invited oral presentation to the Food Sciences Department, Pennsylvania State University, State College, PA.

- 11 - Revised Feb2020

15. Morrow, KM. (October 2009). PrEP: Behavioral Science’s Role in Developing the PreClinical Pipeline. Invited oral presentation, NIH/NIAID Workshop: Beyond 2010: Gaps, Challenges, and Priorities for the Future of PreClinical PrEP, Washington, D.C. 16. Morrow, KM. (November 2009). The Role of a Phase I Trial in Product Development: Behavioral Perspectives. Invited oral presentation, NIH Workshop: Best Practices for Phase 1 Assessment of Microbicide Safety, Washington, DC. 17. Morrow, KM. (January 2010). Acceptability of Different Dosage Forms. Invited oral presentation, CONRAD: Trends in Microbicide Formulation Workshop. Arlington, VA. 18. Morrow, KM. (February 2012). Vaginal Microbicides: Engineering Pleasure to Empower Women. Invited oral presentation to the Women’s Medicine Collaborative, Lifespan. Providence, RI, USA. 19. Morrow, KM (May 2012). Biomedical prevention of HIV: Engineering pleasure to empower women. Invited oral presentation to the Centers for Alcohol & Addiction Studies, Brown University, Providence, RI, USA. 20. Morrow, KM. (February 22, 2013). Optimizing Drug Delivery Systems: The User’s Perspective. Invited oral presentation to the Think Tank on Drug Delivery Systems for HIV Prevention, co-sponsored by the Prevention Sciences Branch, Division of AIDS, National Institute of Allergies and Infectious Disease, National Institutes of Health and the Bill and Melinda Gates Foundation. Washington, D.C., USA. 21. Morrow, KM. (March 2015). Reason and Passion: Using Science to Improve Public Health. Presented to the Rhode Island chapter of the Association of Nurses in AIDS Care. Providence, RI, USA. 22. Guthrie, KM. (June 2017). Motivations, Collaborations and Provocations: The Challenges of MPT Development. Invited panel presentation to the Think Tank on Multipurpose Prevention Technology (MPT) Development: Strategies for Addressing Biomedical, Behavioral, and Regulatory Challenges, sponsored by the Division of AIDS, National Institute of Allergies and Infectious Disease, National Institutes of Health

Invitations from International Organizations/Conferences 23. Morrow, KM. (March 1997). Behavioral medicine: Psychology’s role in disease prevention. Invited presentation at the Department of Psychology, St. Mary’s University, Halifax, NS, Canada. 24. Morrow, K, Tolley, E. (January 2005). Microbicide acceptability: Measuring what lies beneath the surface. Presented at the Annual Meeting of the Alliance for Microbicide Development, Washington, DC. 25. Morrow, KM. (February 2008). Microbicide Formulations and Delivery Systems: Behavioral Perspectives. Invited Keynote Address to the Microbicides 2008 Conference, New Delhi, India. 26. Morrow, KM. (October 2009). The Tools of Our Trade: What We Have and Where We Need To Go. Invited oral presentation at the Annual Meeting of the Alliance for Microbicide Development, Washington, D.C. 27. Morrow, KM. (October 26, 2012). Product Design Issues. Invited oral presentation to the MPT Product Prioritization Stakeholder Meeting; Sponsored by the Coalition Advancing Multipurpose Innovations (CAMI). Washington, D.C., USA. 28. Morrow, KM. (July 2014). From the Booty's Point of View: Using Perceptibility Data to Inform Rectal Microbicide Development. Webinar presented at the International Rectal Microbicide Advocates. 29. Morrow, KM. (May 2015). Perceptibility: Understanding User-Centered Experiences in Drug Development. Invited oral presentation to the International Conference on Antiviral Research (International Society on Antiviral Research). Rome, Italy. 30. Guthrie, KM. (Dec 2017). Driving Impactful End-User Research for More Insightful MPT Development. Invited panelist to the Initiative for Multipurpose Prevention Technologies for Reproductive Health (IMPT). International Webinar. ABSTRACTS ** signifies presentations where Dr. Guthrie (née Morrow) served as either a primary mentor, or qualitative methodology mentor; fellow or junior faculty trainee is underlined.

National Conferences 1. Morrow, K.M., Meinhold, P.M., & Fuqua, R.W. (1994, April). Incidence of HIV-related risk behaviors and seropositivity in the lesbian/bisexual women's communities. Presented at the Annual Meeting of the Society for Behavioral Medicine, Boston, MA. 2. Morrow, K.M., Fuqua, R.W., & Meinhold, P.M. (1994, May). Self-reported HIV risk behaviors and serostatus in lesbian/bisexual women. Presented at the American Psychological Association Conference on Psychosocial and Behavioral Factors in Women's Health, Washington, DC. 3. Morrow, K.M. & Fuqua, R.W. (1997, May). Women who have sex with women: Consumer satisfaction with an HIV/STD prevention program. Presented at the National Conference on Women & HIV, Pasadena, CA.

- 12 - Revised Feb2020

4. Bentley, M.E., Morrow, K.M., Chesney, M., Bettencourt, F., Mayer, K. (1997, May). Acceptability research during a Phase I Trial of a new vaginal microbicide: BufferGel. Presented at the National Conference on Women & HIV, Pasadena, CA. 5. Morrow, K., Boland, R., Sedarsky, J., Fiore, T., Gromley, J., Aromin, I., Flanigan, T., & Abrams, D. (1997, May). Support for HIV-positive women: An assessment of needs and barriers to services. Presented at the National Conference on Women & HIV, Pasadena, CA. 6. Morrow, K. (1998, Dec). HIV risk among lesbians and women who have sex with women: Neglected populations. Presented at the annual meeting of the American Anthropological Association, Philadelphia, PA 7. Niaura, R., Shadel, W.G., Morrow. K., Flanigan, T., & Abrams, D.B. (1999, March). Smoking among HIV-positive persons. Presented at the annual meetings of the Society of Behavioral Medicine, San Diego, CA. 8. Morrow, K.M., Farrell, N.C., Lloyd, E.E., & Niaura, R.S. (2000, April). Barriers and benefits of smoking cessation among HIV-positive individuals: A qualitative study. Presented at the annual meetings of the Society of Behavioral Medicine, Nashville, TN. 9. Morrow, K.M. (2001, March). Science Behind Bars: Conducting Behavioral Health Research in Prison. Presented at the annual meetings of the Society of Behavioral Medicine, Seattle, WA. 10. Eldridge, G.D., Morrow, K.M., Seal, D.W., Wolitski, R.J., Zack, B., for the Project START Study Team. (2001, Aug). Developing Interventions for Young Men Being Released From Prison: Research Findings and Lessons Learned from Project START. Presented at the 2001 National HIV Prevention Conference, CDC. 11. Rich, J.D., Morrow, K., Cunliffe, T., Taylor, L., Zampi, A., Osai A., McKenzie, M., Macalino, G. (2001, Aug). Motivational enhancement for physicians prescribing syringes to injection drug users to prevent HIV. Presented at the 2001 National HIV Prevention Conference, CDC. 12. ** Buck J.M., Morrow K.M., Margolis A.D., Eldridge G., Sosman J., Binson D., MacGowan R.J., Kacanek D., Flanigan T., and the Project START Study Group. (January 2003). Hepatitis B Vaccination in prison: The perspective of former inmates. Presented at the Hepatitis Coordinators Conference: San Antonio, Texas. 13. ** Nealey-Moore J., Morrow K., Grinstead O., Eldridge G., Askew J., Fitzgerald C. (March, 2003). Sexual Risk- Taking of Men Released from Prison. Presented at the Annual Meeting of the Society of Behavioral Medicine, Salt Lake City, Utah. 14. Morrow, K., Costello, T., & Rosen, R. (2003, March). Coloring in the Lines: Using Qualitative Data to Enhance Quantitative Findings: The Case of Microbicide Acceptability. Presented at the Annual Meeting of the Society of Behavioral Medicine, Salt Lake City, Utah. 15. Lally M.A., Montstream-Quas S.A., Tanaka S.M., Rosen R.K., Morrow K.M. (2003, July). Barriers and Facilitators for Infectious Disease Testing and Results: What Female Injection Drug Users Are Saying about HIV and Viral Hepatitis. (Abstract 358) Presented at the 2003 National HIV Prevention Conference, Atlanta, GA. 16. Morrow, K. (2003, July). Vaginal microbicides: How did we get here and where are we going? Invited presentation to the 2003 National HIV Prevention Conference, Atlanta, Georgia. 17. Morrow, K., Rosen, R., & Costello, T. (2003, July). Whose stealth is it anyway? Exploring the need for covert microbicide use. Presented at the 2003 National HIV Prevention Conference, Atlanta, Georgia. 18. ** Dove, D.C., Rosengard, C., Morrow, K., & Stein, M.D. (2006, March). Understanding Reasons for Condom Non- Use among Adolescents Based on Sexual Frequency: A Qualitative Analysis. Poster at the Society for Adolescent Medicine Annual Meeting, Boston MA. 19. Morrow, K.M., Vargas, S., Rosen, R.K., Barroso, C., Christensen, A., & Fava, J.L. (2006, May). Community partnership and quota sampling: Recruiting at-risk women for research. Presented at the Centers for Disease Control & Prevention National STD Conference, Jacksonville, FL. 20. ** Rosen, RK, Morrow KM. (2006, November) Acceptability of Pleasure: The sex appeal of vaginal microbicides. Presented at the American Public Health Association Conference, Boston, MA. 21. ** Rosengard, C., Morrow, K., Dove, D., Stein, L. A. R., Lopez, R., Audet, D., & Stein, M. (2007, April). Association between substance use and sexual risk among incarcerated adolescents: The role of partner type, relationship stage, and reasons for condom non-use. Presented at the 2007 Joint Meeting on Adolescent Treatment Effectiveness (JMATE). Washington, DC. 22. ** Dove, D.C., Rosengard, C., Morrow, K., Stein, L.A.R., Lopez, R., Audet, D. A., & Stein, M.D. (2008, March). Incarcerated adolescents’ perspectives and experiences of partner communication about sexually transmitted disease / HIV risk. Poster to be presented at the 2008 National STD Prevention Conference. Chicago, IL.

- 13 - Revised Feb2020

23. ** Houck, C., Hadley, W., Morrow, K.M., Peters, A., & Walker, T. (2008, August). Early Adolescents’ Understanding of Affect Regulation: Implications for HIV Prevention. Presented at the American Psychological Association Annual Meeting, Boston, MA. 24. de Dios, M.A., Stanton, C.A., Lloyd-Richardson, E., Morrow, K., Niaura, R. (2009, April). Quality of life among HIV+ individuals involved in smoking cessation treatment. Poster presented at the 30th Annual Meeting of the Society for Behavioral Medicine, Montreal Canada. 25. ** van den Berg, J.J., Lopez, R., Dove, D.C., Morrow, K.M., Stein, L.A. R., & Rosengard, C. (2009, August). African American and Latino/a Adolescents' Sexual Relationship Perceptions and Motivations. Poster session to be presented at the annual meeting of the American Psychological Association Conference, Toronto, Canada. 26. ** van den Berg, J. J., Lopez, R., Dove, D. C., Morrow, K. M., Stein, L. A. R., & Rosengard, C. (November, 2009). Participant-identified intervention components and facilitator characteristics for an HIV risk reduction program among incarcerated adolescents. Poster session to be presented at the annual meeting of the American Public Health Association Conference, Philadelphia, Pennsylvania 27. ** van den Berg, J. J., Lopez, R., Dove, D. C., Morrow, K. M., Stein, L. A. R., & Rosengard, C. (October, 2009). Teenspeak: The language of inner-city adolescent's sexual behaviors and sexual relationships. Poster session to be presented at the CFAR Social and Behavioral Sciences Research Network National Scientific Meeting, Boston, Massachusetts. 28. Li, S., Dove, D.C., van den Berg, J.J., Lopez, R., Audet, D., Morrow, K. M., Stein, L.A.R., & Rosengard, C. (April, 2010). Sexual health learning and partner communication about sexually transmitted disease/HIV risk: Incarcerated adolescents’ perspectives. Presented at the annual meeting of the Society for Adolescent Medicine, Toronto, Canada. 29. Seal, D.W. and the Project START Team (2011, September). Using qualitative methods: The context of substance use and sexual behavior among 18- to 29-year old men after their release from prison. Invited talk at the North American Housing and HIV/AIDS Research Summit VI. New Orleans, LA. 30. ** LaRose, J.G., Morrow, K.M., Robichaud, E.R., Palmer, K. & Wing, R.R. (September, 2012). Using qualitative research methods to inform treatment development efforts with young adults. Accepted for presentation at the annual meeting of the Obesity Society, San Antonio, TX. 31. Rosen R.K., Jennings E., Thind H., Gaskins R., Morrow K.M., Williams D. & Bock, B. (August 2013) “Smoking does not go with yoga”: Women’s perception of yoga in smoking cessation treatment. Poster to be presented at the 121st annual convention of American Psychological Association, Honolulu, HI. 32. ** Ranney ML, Thorsen M, Patena JP, Cunningham R, Boyer E, Walton M, Spirito A, Zatzick D, Morrow K. (January 2015). "You need to get them where they feel it”. Conflicting Perspectives on How to Maximize the Structure of Text-Message Psychological Interventions for Adolescents." In: Bodendorf, F. Report of the HICSS-48 Information Technology In Healthcare - Mobile & Sensing Solutions for Health Promotion and Maintenance Symposium. 33. ** Chu, A., Lobato, D., Morrow Guthrie, K., Kao, B., Plante, W., & Long, K. (2016). Impact of ASD diagnosis on the emotional experiences of Latino and non-Latino siblings of children with ASD. American Public Health Association, Denver, US. 34. Thind, H., Fava, J.L., Guthrie, K., Stroud, L., Gopalakrishnan, G., Horowitz, S., Walaska, K., Lantini, R., Sillice, M., Gidron, N., Bock, B.C. (Oct, 2017) Yoga as a complementary therapy for patients with type 2 diabetes: An initial investigation. Symposium of Yoga Research (SYR) conference, Stockbridge, MA. 35. Cioe, PA, Gordon, R, Guthrie, K, Freiberg, MS, Kahler, KW. (Feb 2018). Perceived barriers to smoking cessation and perceptions of electronic cigarettes among persons living with HIV. Society for Research on Nicotine & Tobacco (SRNT) Annual Conference, Baltimore, MD. 36. Cioe, P.A.,Merrill, J.E., Gordon, R.E.F, Freiberg, M., Guthrie, K.M., Williams, D.M., Risica, P., Kahler, C.W. (Nov 2018). Personalized feedback improves CVD risk perception and physical activity levels in persons living with HIV: A pilot randomized clinical trial. Presented at the Association of Nurses in AIDS Care 31th Annual Conference, Denver, CO. 37. Samardzic, K. B., Landoll, R. R., Vargas, S., Clark M. F., Guthrie K., & Quinlan, J. D. (2019, May). Interviews in Sexual and Reproductive Health: Exploring the Preparation Phase in a Multiphase Optimization Strategy (MOST) Study. Uniformed Services University Research Days, Bethesda, MD. 38. Baysinger, AN, Aston, ER, Guthrie, KM, Merlin, J, Champion, JD, & Claborn, KR. (2019, June). Prescribing Opioids as Motivational Incentives to Promote Health-Related Behaviors in Patients. Presented at the 2019 College of Problems on Drug Dependence Annual Scientific Meeting. San Antonio, TX.

- 14 - Revised Feb2020

39. Landoll RR, Vargas SV, Samardzic K, Clark MF, Crone B, Witkop C, Jorgensen S, Arnold W, Austin K, Jones G, Gray A, Carey MP, Quinlan JD, Guthrie KM. (2019, Aug). Optimizing a multi-modal intervention to reduce health- risking sexual behavior: Qualitative Narratives. Presented at the 2019 Military Health System Research Symposium, Orlando, FL. 40. Nesi, J., Guthrie, K. Wolff, J. & Sprito, A. (2019, Oct). Social media and suicide risk: Qualitative analysis of social media content and in-depth interviews among psychiatrically-hospitalized adolescents. In J. Wolff (Chair), Cognitive and Interpersonal Processes of Risk for Suicide in Adolescence and Emerging Adulthood. Symposium presented at annual meeting of the International Academy of Suicide Research, Miami, FL.

International Conferences 41. Morrow, K.M. (1993, May). Self-stimulatory behavior as a reinforcer: Effects on language acquisition and free- operant self-stimulation rates. Thesis in partial fulfillment of the requirements for the degree of Masters of Arts in Psychology, West Virginia University, Morgantown, WV. Presented at the Convention of the Association for Behavior Analysis: International, Chicago, IL. 42. Fuqua, R.W., DeLeon I.G., Freemire, S., Rubino, L., O'Hara, T., Morrow, K., & Armstrong, K. (1993, May). "Excuse me, where are your condoms?” An assessment of the natural contingencies involved in purchasing safe sex supplies. Presented at the Convention of the Association for Behavior Analysis: International, Chicago, IL. 43. Thebarge, R.W., Maruyama, N., Pinto, B., Morrow, K., & Cargill, B. (1996, October). Psychological distress in early stage breast cancer. Presented at the Third World Congress of Psycho-Oncology, New York, NY. 44. Marmor, M., Morrow, K., Smith, C., Holte, S., Brown-Peterside, P., Langenbahn, S., Doherty-Iddings, P., & the HIV Network for Prevention Studies (HIVNET). (1998, June). HIV risk behaviors among women who have sex with women (WSWs) enrolled in a high-risk US cohort. Presented at the 12th World AIDS Congress, Geneva, Switzerland. 45. Chesney, M., Bentley, M., Morrow, K., Mayer, K. (1998, June). Real experience: The key to vaginal microbicide acceptability. Presented at the 12th World AIDS Congress, Geneva, Switzerland. 46. Mason, T.H., Foster, S.E., Finlinson, H.A., Morrow, K.M., Vining-Bethea, S., & Seage, G.R. (1998, June). Factors affecting acceptability of vaginal microbicides among drug-involved women: Results of focus groups in three cities. Presented at the 12th World AIDS Congress, Geneva, Switzerland. 47. Solomon, S., Morrow, K, et al. (2001, Oct). Same risks, disparate perceptions: Challenges to microbicide acceptability in Chennai community. Presented at the 6th International Conference on AIDS in Asia and the Pacific, Melbourne, Australia. 48. Morrow, K., Solomon, S., Srikrishnan, A.K., Costello, T., Rosen, R., Mayer, K. (2002, May). Microbicide acceptability in southern India: A quantitative survey. Presented at International Microbicides Conference 2002, Antwerp, Belgium. 49. Morrow, K., Rosen, R., Richter, L., Emans, A., Forbes, A., Day, J., Morar, N.S., Maslankowski, L., Profy, A., Kelly, C., Abdool Karim, S., Mayer, K. (2002, May). The acceptability of an investigational vaginal microbicide agent: Pro 2000 Gel. Presented at International Microbicides Conference 2002, Antwerp, Belgium. 50. Day, J., Morrow, K., Rosen, R., Abdool Karim, S.S., Emans, A., Maslankowski, L., Mayer, K. & the HPTN 020 Protocol Team (May 2002). How to Find Out What Men Think: Lessons learned from a Microbicide Clinical Trial (Abstract No. C-256). International Microbicides Conference 2002, Antwerp, Belgium. 51. Seal D.W., Margolis A.D., Binson D., Morrow K., Eldridge G., Kacanek D., Belcher L., Sosman J., and the Project START Study Group. (July 2003). HIV, STD, and Hepatitis Risk Behavior among 18-29 Year Old Men Incarcerated in the United States. XIV International AIDS Conference, Barcelona Spain. 52. ** Rosen, R., Morrow, K., Carballo-Diéguez, A., Fry, D., Mantell, J., Negrón, J., Costello, T., Hoffman, S., Maslankowski, L., El-Sadr, W., Mayer K. (2004, March). The Acceptability of a Novel Vaginal Microbicide, PMPA Gel, Among Female Users: HPTN 050. Presented at the International Microbicides Conference 2004, London, England. 53. Morrow, K., Rosen, R., Carballo-Diéguez, A., Fry, D., Kulczycki, A., Negrón, J., Costello, T., Forbes, A., El-Sadr, W., Maslankowski, L., Mayer, K., & the HPTN 049 Study Group. (2004, March). The Acceptability of a Novel Vaginal Microbicide, Cellulose Sulfate Gel, Among HIV-Positive Females: HPTN 049. Presented at the International Microbicides Conference 2004, London, England. 54. Carballo-Diéguez, A., Morrow, K., Rosen, R., Negrón, J., Balan, I., Fry, D., Costello, T., Mantell, J., Hoffman, S., Mayer, K., El-Sadr, W., Maslankowski, L., & the HPTN 050 Study Group. (2004, March). Male partners’ acceptability of PMPA gel as vaginal microbicide: HPTN 050. Presented at the XV International AIDS Conference.

- 15 - Revised Feb2020

55. Wolitski, R.J. & the Project START Study Group. (2004, July). Project START reduces HIV risk among prisoners after release. Presented at the XV International AIDS Conference. Med Gen Med. 2004 Jul 11; 6(3):WeOrC1296 [eJIAS. 2004 Jul 11;1(1):WeOrC1296]. *Dr. Morrow was the Principal Investigator for the Rhode Island site. 56. Hoffman, S., Morrow, K.M., Mantell, J.E., Carballo-Dieguez, A., Rosen, R.K., Gai, F., for the HPTN 050 Study Team. (2006, April). Covert Use of a Vaginal Microbicide: Views of Women Participating in a Phase I Trial of Tenofovir Gel (HPTN 050). Presented at the International Microbicides Conference 2006, Cape Town, South Africa. 57. Morrow, K.M., Fava, J.L., Rosen, R.K., Christensen, A., Vargas, S. and Barroso, C. (2006, April). Willingness to Use Vaginal Microbicides Varies by Race/Ethnicity, Partner Type, and Experience with Vaginal Products. Presented at the International Microbicides Conference 2006, Cape Town, South Africa. 58. Morrow, K.M., Rosen, R.K., Mayer, K.H., Maslankowski, L., and El-Sadr, W.M. (2006, April). The effect of formulation factors on vaginal microbicide acceptability: A meta-analysis of qualitative data from three Phase I clinical trials in the United States. Presented at the International Microbicides Conference 2006, Cape Town, South Africa. 59. Morrow, K.M. & Ruiz, M.S. (2006, April). Measuring Microbicide Acceptability in Preclinical and Clinical Trials. Presented at the International Microbicides Conference 2006, Cape Town, South Africa. 60. ** Rosen, R.K., Morrow, K.M., Lakshmi, .S, Srikrishnan, A.K., Dhawan, D., Solomon, S. & Mayer, K.H. (2006, April). The acceptability of vaginal microbicide use among women in Chennai: A qualitative study conducted among low- and high-risk women. Presented at the International Microbicides Conference 2006, Cape Town, South Africa. 61. Morrow, K.M., Srikrishnan, A.K., Rosen, R.K., Lakshmi, S., Dhawan, D., Solomon, S., Mayer, K.H. (2006, April). Acceptability of vaginal microbicide use in Chennai, India: A qualitative study among low- and high-risk men. Presented at the International Microbicides Conference 2006, Cape Town, South Africa. 62. Morrow, K.M., Rosen, R.K., Henderson, M., Vargas, S., Barroso, C., Katz, D. (2008, February). Co-optimizing Vaginal Microbicide Gel Acceptability and Vaginal Deployment. Poster presented at the International Microbicides Conference 2008, New Delhi, India. 63. Morrow, K.M., Fava, J.L., Rosen, R.K., Vargas, S., Barroso, C. (2008, February). A Contextual Model of Microbicide Acceptability. Oral presentation to the International Microbicides Conference 2008, New Delhi, India. 64. Wang, C.J., Machan, J.T., Wong, W.W., Wang, T.H., Liao, S.T., Wu, T.Z., Young, T.G., Wang, L.S., Yen, M.Y., Morrow, K.M., & Mayer, K.H. (2009, February). Disclosure of HIV serostatus did not affect condom use among HIV-infected men who have sex with men in Taipei, Taiwan. Abstract #Y-156. 16th CROI 2009, Montreal, Canada. 65. Morrow, K.M., Fava, J.L., Rosen, R.K., Kiser, P., & Katz, D. (March, 2009). Linking biophysical functions to user perceptions and acceptability in preclinical product development. Poster presented at the 1st International Symposium on Advancing Prevention Technologies for Sexual and Reproductive Health: A Strategy Symposium, Berkeley, CA. 66. Morrow, KM, Fava, JL, Kiser, P, Rosen, RK, & Katz, D (May, 2010). The LINK between gel properties and user perceptions: Implications for rationale design of microbicides. Oral presentation at the International Microbicides Conference 2010, Pittsburgh, PA, USA. 67. Morrow, KM, Rosen, RK, Vargas, S, Barroso, C, Kiser, P & Katz, D. (May, 2010). User-Identified vaginal gel characteristics: A qualitative exploration of perceived product efficacy. Oral presentation at the International Microbicides Conference 2010, Pittsburgh, PA, USA. 68. Morrow, KM, Rosen, RK, van den Berg, J, Kiser, P, Katz, D, Buckheit, K, Buckheit, R Jr, & the ImQuest IPCP- HTM Study Team. (April, 2012). User experience shapes 'meaning making' and the acceptability of intravaginal rings and long-acting vaginal gels. Oral presentation at the International Microbicides Conference 2012, Sydney, Australia. 69. Morrow, KM, Fava, JL, Katz, D, Kiser, P, Rosen, RK, Kojic, EM, Friend, D, & the Project LINK Study Team. (April, 2012). User sensory perceptions and experiences of vaginal gels correspond to gel properties and performance: The impact on willingness to use. Oral presentation at the International Microbicides Conference 2012, Sydney, Australia. 70. Morrow, KM, Coffey, PS, Kilbourne-Brook, M. (April, 2012). SILCS Diaphragm for delivery of microbicide gel: an exploratory study of user acceptability. Oral presentation at the International Microbicides Conference 2012, Sydney, Australia. 71. Lumby, E, Ruiz, MS, Morrow, KM, Galea, JT, Pickett, J, & LeBlanc, MA. (April, 2012). Common problems with lubricants for anal sex: Challenges for rectal microbicide developers. Presented at the International Microbicides Conference 2012, Sydney, Australia. 72. Morrow, KM, Dunsiger, S, Fava, JL, Shaw, JG, Rosen, RK, Kiser, P, Friend, D, Katz, D, & the Project LINK Study Team. (July, 2012). Which user experiences potentiate adherence to vaginal microbicides?: What user characteristics

- 16 - Revised Feb2020

predict product experience, and which experiences predict use?. Presented at the XIX International AIDS Conference (AIDS 2012), Washington DC, USA. 73. ** Kuhl, E.S., Hart, C.N., Morrow, K., Nitkin, B., & Jelalian, E. (April, 2013). How do we build it so they will come? Developing a family and community-based obesity intervention for preschoolers from low-socioeconomic backgrounds. Poster presented at the National Conference in Pediatric Psychology, New Orleans, LA. 74. Morrow, KM. Characterizing Product Properties: Perceptibility and Willingness. (May, 2014). Presented at the Microbicide Trial Network’s Creating Desire for Microbicides Conference, Arlington, VA. 75. Morrow, KM, Dunsiger, S, Fava, JL, Rosen, RK, Vargas, SV, Shaw, JG, & the Project LINK Study Team (June, 2014). Choosing Prevention: The Case for Involving Users in Early Microbicide Development. Presented at the 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL. 76. Morrow, KM, Rosen, RK, Fava, JL, Rohan, L, Kojic, EM, Friend, D, Katz, D, & Buckheit, R. (Oct, 2014). “He Said, She Said.” Exploring Couples’ Sensory Perceptions and Experiences with Vaginal Gels & Film: Implications for Microbicide Development. Accepted for oral/poster presentation at the International HIV R4P (Research for Prevention) Conference: Cape Town, South Africa. 77. Morrow, KM, Rosen, RK, Vargas, S, Katz, D, Fava, J, Kojic, EM, Friend, D, Rohan, L, Ham, A & Buckheit, R. (Oct, 2014). More…? Less…? Just right…? The Role of Perceived Volume in Gel and Film Perceptibility During Intercourse, and its Impact on Product Preference. Accepted for oral/poster presentation at the International HIV R4P (Research for Prevention) Conference: Cape Town, South Africa. 78. Morrow, KM, Rohan, L, Rosen, RK, Fava, JL, Ham, A, Friend, D, Katz, D, Kojic, EM, & Buckheit, R. (Oct, 2014). Vaginal Film User Evaluations: Developer Considerations from Initial Impressions and User Sensory Perceptions and Experiences during Vaginal Sex. Accepted for oral/poster presentation at the International HIV R4P (Research for Prevention) Conference: Cape Town, South Africa. 79. Morrow, KM. (May, 2015). Perceptibility: Understanding User-Centered Experiences in Drug Development. Invited oral presentation to the International Conference on Antiviral Research (International Society on Antiviral Research). Rome, Italy. 80. Claborn, K.R., Guthrie, K., Ramsey, S., & Saccoccio, M. (2016, May). Utility of Patient Navigators to Improve Care Continuum Outcomes among HIV-infected People Who Use Drugs. Presented at the annual meeting of the International Association of Providers of AIDS Care, Fort Lauderdale, Florida. 81. Underhill, K, Guthrie, KM, Operario, D, Calabrese, S, Colleran, C, & Mayer, KH. (2016, July). A qualitative study of PrEP stigma, pride, and predicted community benefits among MSM and male sex workers. Presented at the International AIDS Conference: Durban, South Africa. 82. Guthrie, KM, Fava, JL, Vargas, SE, Guillen, M, Getz, ML, Rosen, RK, Smith, KA, Breakey, JC, Fuchs, EJ, Ham, AS, Weld, ED, Katz, DF, Hendrix, CW, Buckheit, KW, Buckheit, RW. (2016, October). Measuring Sensory Experiences Elicited by Product Properties during Receptive Anal Sex: Implications for Prevention Design and Marketing. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. 83. Guthrie, KM, Vargas, SE, Guillen, M, Rosen, RK, Steger, A, Getz, ML, Smith, KA, Woodrow, KA. (2016, October). Incorporation of Early End User Feedback into the Iterative Design of Fiber-Based Microbicides: Considering Adherence from Inception. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. 84. Guthrie, KM, Vargas, SE, Rosen, RK, Dawson, LN, Getz, ML, Guillen, M, Smith, KA, Baum, MM, Vincent, KL. (2016, October). Initial Feasibility, Acceptability, and User Experience of a Multi-Drug Pod-IVR: A Mixed Methods Study. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. 85. Katz, DF, Ham, A, Smith, J, Guthrie, KM, Simons, M, Gao, Y, Peters, J, Yuan, A, Henderson, M, Pereira, L, Singletary, T, Fava, JL, Vargas, SE, Buckheit, K, Murtha, A, Buckheit, RW. (2016, October). Do Microbicide Gel Volume and Properties Matter?: Effects on Deployment, PK and User Sensory Perceptions and Experiences. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. 86. Vincent, KL, Pyles, RB, Moss, JA, Gunawardana, M, Smith, TJ, Guthrie, KM, Reyzer, ML, Marzinke, MA, Hendrix, CW, Baum, MM. (2016, October). A Phase I Crossover Trial of Intravaginal Rings Delivering Antiretroviral Agents. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. 87. Katz, DF, Simons, M, Peters, J, DeSoto, M, Henderson, M, Wax, A, Spiegel, H, Singletary, T, Fava, JL, Vargas, SE, Guthrie, KM. (2016, October). Vaginal Gel Surface & Coating Thickness Distribution Using Novel Optical Imaging and Correlation with User Sensory Perception/experience (USPE) Scales. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. - 17 - Revised Feb2020

88. Tolley, E, Guthrie, KM, Zissette, S, Louw, CE, Kotze, P, Gill, K, Reddy, K, MacQueen, K. (2016, October). Development and Validation of Measures to Screen for Potential Adherence and Support Adherence Prospectively. Presented at International HIV Research for Prevention (HIV R4P) Conference, Chicago, IL, USA. 89. Nesi, J., Guthrie, K. Wolff, J. & Sprito, A. (October, 2019). Social media and suicide risk: Qualitative analysis of social media content and in-depth interviews among psychiatrically-hospitalized adolescents. In J. Wolff (Chair), Cognitive and Interpersonal Processes of Risk for Suicide in Adolescence and Emerging Adulthood. Symposium presented at annual meeting of the International Academy of Suicide Research, Miami, FL. 90. Cu-Uvin, S, Moench, T, Politch, JA, Tashima, KT, Marathe, JG, Guthrie, KM, Cabral, H, Nyhuis, TJ, Brenna, M, Zeitlin, L, Spiegel, HM, Mayer, KH, Whaley, K, & Anderson, D. (2020, March). Phase 1 Placebo-Controlled Safety, PK, and PD Study of Mb66 Anti-HIV and Anti-HSV Film. Oral presentation at the Conference on Retroviruses and Opportunistic Infections (CROI: International Antiviral Society (IAS)), Boston, MA.

OTHER SCIENTIFIC PRESENTATIONS/CONTRIBUTIONS

Kemp, K & Guthrie KM. (March 2018). Introduction to Qualitative and Mixed Methods. Day-long Pre-Conference Workshop. Presented at the American Psychology-Law Society (Division 41). Memphis, TN.

RESEARCH GRANTS

Active 2014-2019 Principal Investigator/Perceptibility Studies (Project 4); Co-Investigator/Overall U19. NIAID U19 AI113048. “Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention.” (Baum, PI $3,333,050; Guthrie, PI $242,154). 2016-2019 Co-Investigator. NIAAA R34 AA023158. “Reducing Alcohol-related HIV/STI Risk for Women in Reproductive Health Clinics.” (Carey, MP, PI $201,710). 2017-2022 Co-Investigator. USUHS VPR-27320915. “Optimizing a Multi-Modal Intervention to Reduce Health- Risking Sexual Behavior.” (Landoll, PI; Vargas, Co-I $52,185).

Previously Funded 1993 Principal Investigator. "Culturally appropriate HIV/AIDS prevention strategies for the lesbian and bisexual women's communities." Western Michigan University, Graduate Student Research Fund. Dissertation Research. 1994 Principal Investigator. "Culture-specific HIV/STD prevention programming for lesbian and bisexual women." Chicago Resource Center. Dissertation Research. 1996-1997 Co-Investigator. “Integrating Primary Care with Outpatient Treatment in HIV-Positive Women.” Brown University, Department of Psychiatry & Human Behavior, Faculty Development Award (Boland, PI). 1997-2001 Investigator/Intervention Coordinator. “HIV/AIDS high risk behavior prevention intervention model for young adults and adolescents.” SAMHSA. 1997-2004 Principal Investigator. “HIV and STD intervention research for young men in prison.” CDC. 1998-2003 Co-Investigator. “Motivation and Patch Treatment for HIV-Positive Smokers.” NCI. 1998-2017 Co-Investigator. NIAID P30AI042853. “Lifespan/Tufts/Brown Center for AIDS Research” 1999-2001 Principal Investigator. “Reducing HIV Risk in Substance Abusing Women: A Pilot.” NIDA-R03. 2001-2008 Principal Investigator. “A Contextual Model of Microbicide Acceptability.” NIMH/ORWH-R01. 2005-2010 Co-Investigator. “Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking.” NIDA. 2006-2008 Co-Investigator. “Seamos Activos: Increasing Activity among Latinas.” NINR-R21 2006-2008 Principal Investigator. “Measuring Microbicide Acceptability in Adolescent Women in the United States and South Africa.” Brown University National Center of Excellence in Women’s Health. 2006-2012 Principal Investigator. “Linking Biophysical Functions of Microbicides to User Perception & Acceptability.” NIMH/OWHR R21/R33 Microbicide Innovation Program, R21/R33 MH080591 2007-2010 Co-Investigator. “Affect Management Intervention for Early Adolescents with Mental Health Problems.” NIMH-R34 2007-2010 Co-Investigator. “Yoga for Women Attempting Smoking Cessation: An Initial Investigation.” NCCAM- R21.

- 18 - Revised Feb2020

2007-2010 Co-Investigator. “Feasibility and Acceptability of SILCS Diaphragm as a Microbicide Delivery System.” USAID 2008-2013 Principal Investigator Subcontract/Project Leader (Project 3); Co-Investigator (overall U19). “Long Acting Acceptable Microbicides: Novel Delivery, Activity & Pharmacodynamics.” (Buckheit, PI) NIAID U19 AI077289. 2009-2011 Co-Investigator. “Examining a Text Message Intervention for Smoking Cessation. NIDA R21 2009-2011 Principal Investigator. “Linking Biophysical Functions of Microbicides to User Perception & Acceptability.” NIMH- Supplement to R33 MH080591. 2009-2012 Principal Investigator. “Evaluation of the Behavioral Measures of Acceptability of Two Vaginal Gels.” PPA-09-023 CONRAD Contract. 2009-2013 Co-Investigator. “Culturally and Linguistically Adapted Physical Activity Intervention for Latinas.” (Marcus, PI). NINR R01 NR011295. 2009-2013 Principal Investigator Subcontract; Co-Investigator. “Rational Development of Combination Microbicide Therapies.”(Buckheit, PI). NIAID R33AI076967. 2011-2016 Principal Investigator Subcontract; Co-Investigator. NIAID R21/R33 AI094514. “Designing Optimal Microbicide Delivery Integrating Rheology and Acceptability.” (Hayes, PI). 2011-2018 Co-Investigator. NIAID U19AI096398. “Monoclonal Antibody-Based Multipurpose Microbicides.” (Anderson, PI $2,408,349; Cu-Uvin, sub-PI $366,299). 2012-2014 Principal Investigator. NIAID U19AI096398-Supp “Supplement: Monoclonal Antibody-Based Multipurpose Microbicides.” (Anderson, PI; Morrow, sub-PI). 2012-2018 Principal Investigator. NICHD K24HD062645. “Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship.” (Guthrie, PI; $137,856) 2012-2018 Principal Investigator/Perceptibility Studies (Project 5); Co-Investigator/Overall U19. NIAID U19 AI101961. “Development and Evaluation of Dual Compartment Combination Microbicides.” (Buckheit, PI $2,443,193; Guthrie, PI $397,781)). 2014-2018 Principal Investigator/Perceptibility Studies; Co-Investigator/R01 NIAID R01 AI112002. “Combination HIV prevention in drug-eluting fibers: designing for efficacy and use.” (Woodrow, PI $567,268; Guthrie, PI $285,216). 2015-2017 Co-Investigator. NCCIH R21AT008830. “Yoga as a Complementary Therapy for Type 2 Diabetes: An Initial Investigation.” 2016-2017 Principal Investigator. NIAID U19AI096398-Supp “Supplement-2: Monoclonal Antibody-Based Multipurpose Microbicides.” (Anderson, PI; Guthrie, PI, Supp $219,000).

UNIVERSITY TEACHING ROLES

1992-1993 Graduate Teaching Assistantship (Instructor): Department of Psychology, Western Michigan University. General Psychology (Psy100) (Instructor for two semesters) 1994-1995 Graduate Teaching Assistantship (TA): Advanced Statistics (Psy 634); Correlation and Regression Analysis (Psy 635); Experimental Design (Psy 636); Advanced Data Analysis (Psy 637); Research Methods in Applied Behavior Analysis (Psy 608); Behavioral Medicine (Psy 560) 1994-1995 Guest Lecturer: Western Michigan University: AIDS: History of an Epidemic (HHS569), Abnormal Psychology (Psy 250), and Human Sexuality (Psy 524) 1996-2013 Lecturer: Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University. Pre-doctoral Core Seminar Series: Gay and Lesbian Issues. 1997-present Research Supervisor, Pre-doctoral Internship. Department of Psychiatry and Human Behavior, Brown University Clinical Psychology Training Consortium, Behavioral Medicine Track. (as available) 1997-2008 Guest Lecturer: Department of Anthropology/Department of Community Health, Brown University. AIDS: An International Perspective (BC0168). 1998-2017 Lecturer: Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University. Pre-doctoral Behavioral Medicine Track: HIV Prevention Interventions; Assessing HIV Risk. 1998-present Faculty Mentor: Brown University Senior Honors Theses and Medical School students. (as available) 1998-present Faculty Research Mentor, Postdoctoral Research and Clinical Fellows. Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University; Department of Community

- 19 - Revised Feb2020

Health, Brown University; Department of Behavioral and Social Sciences, Brown University School of Public Health. (as available) 1999-2017 Adjunct Training Faculty, Center for Alcohol and Addictions Studies, Brown University. 1999-2003 Guest Lecturer: Department of Psychology, Brown University. Behavioral Medicine (PY0130). 2000-2017 Adjunct Training Faculty, International Health Institute, Brown University (as needed) 2001-2004 Guest Lecturer: Department of Community Health, Brown University: Introduction to Public Health (BC0032). 2002 Faculty Preceptor: Warren Alpert Medical School of Brown University: Medical Interviewing (BI 371). 2002-present Faculty Mentor: NIH K-Award Recipients and junior faculty (see “Mentoring” table below). 2003 Faculty Mentor, Group Independent Study Projects (GISP: A Kirkley, J Fuerch, J Chang), Brown University undergraduate course. HIV/AIDS as a Private Phenomenon: Individuals and their interactions with the disease. 2003-2005 Adjunct Assistant Professor: Department of Psychology, Providence College, Providence, RI: Introduction to Psychology (PSY100); Health Psychology (PSY225). 2008-2017 Director, Introduction to Qualitative Methods Seminar Series, Centers for Behavioral & Preventive Medicine, The Miriam Hospital, Warren Alpert Medical School of Brown University. 2010 Guest Lecturer: Anthropology Department, Brown University: AIDS in Global Perspective (Anthropology 1020). 2011-2013 Faculty Lecturer. BIARI (Brown International Advanced Research Institutes), Global Health Institute, Office of International Affairs, Brown University. 2014-present Lecturer and Research Mentor. Concentration in Women’s Reproductive Health, Alpert Medical School of Brown University. (as requested) 2015-present Guest Lecturer. Qualitative Methods in Health Research (PHP 2060). Brown University School of Public Health. 2017-present Director, Qualitative Science Methods & Training Program (QSMTP), Centers for Behavioral & Preventive Medicine (The Miriam Hospital) & Department of Psychiatry & Human Behavior (Alpert Medical School of Brown University).

- 20 - Revised Feb2020

MENTORING

Name; Degree/Institution & Year Awarded; Research Interest; Mentorship, years; Mentoring/Advising Provided; Current Position; Funding (associated with mentorship relationship with Dr. Guthrie) Previous Mentees Theresa Costello; PhD, Boston College, 1999; HIV mental health treatment, HIV prevention; Mentored 1999-2001. Provided clinical supervision in the practice of clinical psychology and in clinical research. Dr. Costello is a licensed psychologist in private practice. Jill Nealey-Moore; PhD, University of Utah, 2002; HIV prevention; couples interventions; Mentored, 2001-2003. Provided mentorship in behavioral intervention research during a grant funded post-doctoral fellowship with Dr. Guthrie. Dr. Moore is a licensed psychologist and Associate Professor of Psychology at the University of Puget Sound, WA. Cynthia Rosengard; PhD, University of Connecticut, 1994; MPH, Brown University, 2005; HIV, STI, & Unplanned Pregnancy prevention in at- risk adolescents; Mentored 2002-2007, during K01 implementation; Provided mentorship in qualitative methods for intervention development. Provided training in conduct of individual in-depth interviews and use of IDI data in the development of interventions for the prevention of HIV/STI/pregnancy among at-risk youth. Dr. Rosengard is Associate Professor of Behavioral & Social Sciences, Brown University School of Public Health, and Associate Professor of Medicine, Alpert Medical School of Brown University, RI. Funding: K01MH067490 (PI), R01DA022921 (PI) Rochelle Rosen; PhD, Brown University, 2002; Microbicide Acceptability; Development of Culturally Tailored Health Promotion Interventions; Mentored 2002-2004; Provided mentorship in using qualitative and mixed methods to develop psychometrically validated measures and biomedical interventions. Continues to collaborate with Dr. Rosen on multiple projects and publications. Dr. Rosen is Assistant Professor of Behavioral & Social Sciences, Brown University School of Public Health, RI. She serves as qualitative methodologist and Co-I for the majority of Dr. Guthrie’s research awards. Jennifer Mitty; MD, New York University, 1991; MPH, Harvard University, 1997; HIV secondary prevention; Mentored 2003-2008 during K23; Provided mentorship in qualitative methods for intervention development. Provided training in the conduct of individual in-depth interviews and the use of IDI data in the development of interventions for the secondary prevention of HIV infection among substance-involved HIV-infected individuals. Dr. Mitty is Director, Infectious Disease Fellowship Training Program at Beth Israel Deaconess Medical Center, Boston, MA, and Assistant Professor of Medicine, Harvard Medical School, Boston, MA. Funding: K23DA017622 (PI) Michelle Lally; MD, Univ. of Virginia School of Medicine, 1993; MSc, Harvard SPH, 1999; Vaccination Acceptability in Youth; Mentored 2004-2005; Provided informal mentorship and guidance for conceptualization of qualitative studies within Dr. Lally’s broader research objective, and served as “consultant” as questions regarding qualitative data collection, and analysis. Dr. Lally is Associate Professor of Medicine, Associate Professor of Health Services, Policy and Practice, Director of Brown AIDS Center (CFAR), Director of Brown University AIDS Program (BRUNAP), RI. Funding: K23DA000460 (PI) Carolyn Rabin; PhD, Rutgers U, 2002; Cancer Survivorship in Emerging Adulthood; Mentored 2004-2009; Provided mentorship in grantsmanship involving qualitative methodology, provided mentorship on qualitative methods in individual in-depth interviews, data coding and analyses. Providing guidance on qualitative manuscript preparation to help disseminate focus group findings. Dr. Rabin is Core Faculty of William James College’s Psychology doctoral program and Director of the Health Psychology Concentration. Funding R03CA134197 (PI), Mentored Research Scholar Grant Award, American Cancer Society (PI). Ernestine Jennings; PhD, Oklahoma State U, 2006; Physical activity; Smoking cessation; Minority recruitment and retention in clinical trials; Mentored 2006-2007; Provided training in qualitative methods utilized in analyzing treatment outcome data; provided input into the process of qualitative data collection and assisted with analyzing and interpreting data, and preparing manuscript for publication. Dr. Jennings is Assistant Professor of Psychiatry & Human Behavior, Alpert Medical School of Brown University, RI Funding: NL64342, DA21729 (Investigator Diversity Supplement) Christine Duffy; MD, Cornell Univ. Medical College, 1998; MPH, Brown University, 2003; Breast Cancer and Fertility; Mentored 2007-2008; Provided mentorship in planning and implementing qualitative and mixed methods (focus group and cognitive interviews). Mentorship in using qualitative data to design decision-making aids. Dr. Duffy is Assistant Professor of Medicine, Alpert Medical School of Brown University, RI. Funding: K07CA123337 (PI) Jessica LaRose; PhD, Univ. Central Florida, 2006; Obesity prevention and treatment during emerging adulthood; Mentored 2007-2012; Provided mentorship during her K23 award in grantsmanship involving qualitative methodology, focus group implementation, and data coding and analyses, as well as qualitative manuscript preparation. Dr. LaRose is Assistant Professor of Social and Behavioral Sciences, Virginia Commonwealth University School of Medicine. Funding: K23 DK083440 (PI) Christopher Houck; PhD; Univ. of Florida, 2002; Sexual Risk in Early Adolescence; Mentored 2007-2010; Provided mentorship in qualitative methods for intervention development, training in the conduct of individual interviews and the use of such data in the development of focus group agendas, guidance in the conduct of focus groups, as well as data analysis,and application to a sexual risk prevention intervention for early adolescents with mental health problems. Dr. Houck is Associate Professor of Psychiatry & Human Behavior and Associate Professor of Pediatrics, Alpert Medical School of Brown University, RI. Funding: R34MH078750 (PI), R01NR011906 (PI)

- 21 - Revised Feb2020

Jacob van den Berg; PhD, Univ. of Florida, 2008; HIV prevention; HIV/AIDS-related stigma; sexuality; LGBT mental health; health disparities; Mentored 2010-2011. Dr. van den Berg began working with Dr. Guthrie while a T-32 fellow (2008-2010) and completed a 3rd year of fellowship with Dr. Guthrie to continue qualitative research training. Dr. van den Berg is Assistant Professor of Medicine, Alpert Medical School of Brown University, and Assistant Professor of Behavioral & Social Sciences, Brown University School of Public Health. Funding: P30-DA13868 (CDAAR Developmental Award PI) Rebecca Swenson: PhD. SUNY Albany, 2007; prevention research, health disparities, sexual health; Mentorship in qualitative methodology and using qualitative data to design effective behavioral interventions. Dr. Swenson was Assistant Professor, Department of Psychiatry & Human Behavior, Alpert Medical School of Brown University, RI. Funding: R21 MH095626-02 (PI). Marina Tolou-Shams; PhD, University of Illinois at Chicago, 2004; HIV/STD Risk in Correctional Youth; Mentored 2008-2013; Provided mentorship during K23 in focus group methodology, qualitative data collection and analysis, specifically as it relates to collecting and translating sensitive information. Providing guidance on qualitative manuscript preparation to disseminate findings. Dr. Tolou-Shams was Associate Professor of Psychiatry & Human Behavior Alpert Medical School of Brown University, RI. She is currently Associate Professor of Psychiatry at University of California, San Francisco. Funding: K23DA021532 (PI) Kristin Long: PhD, University of Pittsburgh, 2012. reciprocal influences between a child’s medical illness/disability and his/her family and cultural context; health disparities in autism diagnosis and treatment; development and evaluation of psychosocial interventions for children with chronic conditions and their families Mentored 2012-2014, qualitative methodology understanding the role of siblings in caring for disabled children; impact on those children. Dr. Long is Assistant Professor of Psychological and Brain Sciences, Boston University, MA. Funding: Under review: K01. Suzannah Creech: PhD, Texas A&M University in College Station; relationships between family functioning, health, and mental health in vulnerable veteran populations, family focused interventions for military and veteran populations. Mentored 2011-2014; Intervention to improve intimate relationships and social support in women veterans, VISN 1 Career Development Award. Dr. Creech is Assistant Professor of Psychiatry & Human Behavior, Alpert Medical School of Brown University, and an Investigator for the VISN17 Center of Excellence for Research on Returning War Veterans, Waco, TX. Megan Ranney: MD, Columbia University College of Physicians and Surgeons, 2004; MPH, Brown University, 2010; the intersection between digital health and injury prevention. Mentored 2013-present. Qualitative methodology, developing effective brief interventions for use in emergency department patients. Dr. Ranney is Assistant Professor of Emergency Medicine, Alpert Medical School of Brown University; and Director and founder of the Brown Emergency Digital Health Innovation Funding: K23 MH095866 (PI). Esther Choo: MD, Yale University School of Medicine, 2001; MPH, Oregon Health and Science University, 2009; women's health and the use of technology in the emergency department Mentored 2013-present. Qualitative methodology, developing effective brief interventions for use in emergency department patients. Dr. Choo was Assistant Professor of Emergency Medicine, Alpert Medical School of Brown University; she is currently transitioning to a faculty position at OHSU. Funding: K23 DA031881-03 (PI). Elizabeth Kuhl: PhD, Eastern Michigan University, 2009. Mentored 2012-present. Qalitative methodology, developing early interventions in preschool obesity prevention. Dr. Kuhl is Assistant Professor of Pediatrics, Wayne State University School of Medicine. Funding: R21 HD078890-01 (PI). Kristen Underhill: DPhil in Evidence-Based Social Intervention, University of Oxford, 2007; and JD, Yale Law School, 2011; legal research focuses on law and public health, the use of behavioral science concepts in the law, and healthcare financing; public health research focuses on biomedical HIV prevention, Pre-Exposure Prophylaxis (PrEP); Mentored 2010-2016. Grantsmanship, methods for assessing acceptability and behavioral implications of biomedical prevention; qualitative design and analysis. Dr. Underhill is Associate Research Scholar in Law, Yale University School of Law, and affiliated with the Center for Interdisciplinary Research (CIRA), Yale University. Funding: K01 MH093273 (PI). Sara Vargas: PhD, University of Miami, 2012; health behavior theory, sexual health, health disparities Mentored 2013-2016, grant funded post-doctoral fellowship (Guthrie); Qualitative and mixed methodology in sexual and reproductive health research. Dr. Vargas is Assistant Professor of Psychiatry & Human Behavior, Alpert Medical School of Brown University. Deb Banerjee: MD, New York Medical College, internal medicine, pulmonary arterial hypertension and quality of life Mentored 2015-2016; qualitative methods in Pulmonary Arterial Hypertension and Sexual Functioning. Dr. Banerjee is a Fellow in Critical Care Medicine and Pulmonary Critical Care Medicine, Alpert Medical School of Brown University; She is conducting post-doctoral independent qualitative and mixed methods research with Dr Guthrie to characterize sexual function in patients with pulmonary arterial hypertension, in support of developing patient and provider education. Funding: internal. Patricia Cioe: PhD, University of Massachusetts Medical School, Worcester, 2012; levels of perceived risk and risk factor knowledge in HIV- infected adults, including cardiovascular risk; smoking cessation. Mentored 2014-2016; qualitative methods in HIV disease and cardiovascular risk. Dr. Cioe is Assistant Professor of Behavioral and Social Sciences, Brown University School of Public Health. Funding: K23 NR014951 (PI). Kasey Claborn: PhD, Oklahoma State University, 2013; HIV and addictive disorders, health care access, mobile health technologies Mentored 2015-2017; qualitative methods to develop an adherence intervention for HIV-infected drug users (K23 DA039037), and to develop a mobile application to improve care coordination among HIV clinic and substance use treatment providers (R34 DA041237 – pending). Kathleen Kemp: PhD; Mental health, suicide and the juvenile justice system. Mentored 2016-2018; qualitative methods to develop a suicide risk assessment and prevention intervention in the juvenile court system. (K23 MH111606). Alayna Tackett, PhD; e-cigarette use in asthmatic adolescents: Mentored 2017-2018; qualitative methods to develop effective prevention interventions. (F32 HL138734) Valery Danilack, PhD; Mentored 2016-2019; qualitative methods to explore patient and provider experience of labor induction, and provider description and conformity to institutional labor induction standards. Aim is to explore and devise best practices. (K01 HS025013) Sneha Thamotharan, PhD; sexual and reproductive health in young women of color: Mentored 2017-2019; qualitative methods to develop differentiated care models for YWC in SRH. Preparing R21 proposal. (U Colorado, junior faculty, 2019)

- 22 - Revised Feb2020

Current Mentees (does not include other Scholars currently enrolled in the QSMTP) Adam Aluisio, MD; emergency department visits as a sentinel event to increase uptake in HIV testing among injured young adults in Kenya: mentored 2017-present; (K01 resubmission) Nicholas Tarantino, PhD; HIV treatment adherence intervention development in Ghana; mentored 2017-present (K23; NIMH-funded) Elizabeth Thompson, PhD; improving engagement and adherence to outpatient treatment post-hospitalization among teens with psychosis-like symptoms. (K application/resubmission, 2018) Alyssa Norris, PhD; sexual health promotion in sexual minority populations: mentored 2019-present (T32 funded: K submission) LG Rollins, PhD; pregnancy and trauma history. QSMTP seminar 2018-19. Mentored 2019-present (K application, 2019)

- 23 -